KR101451470B1 - 부갑상선호르몬(ｐｔｈ) 수용체 작용물질로서의 단쇄 펩티드 - Google Patents

부갑상선호르몬(ｐｔｈ) 수용체 작용물질로서의 단쇄 펩티드 Download PDF

Info

Publication number
KR101451470B1
KR101451470B1 KR1020117026057A KR20117026057A KR101451470B1 KR 101451470 B1 KR101451470 B1 KR 101451470B1 KR 1020117026057 A KR1020117026057 A KR 1020117026057A KR 20117026057 A KR20117026057 A KR 20117026057A KR 101451470 B1 KR101451470 B1 KR 101451470B1
Authority
KR
South Korea
Prior art keywords
aib
phe
nle
eiq
har
Prior art date
Application number
KR1020117026057A
Other languages
English (en)
Other versions
KR20120034606A (ko
Inventor
라제시 바헤카르
무굴 알. 자인
판카즈 알. 파텔
Original Assignee
카딜라 핼쓰캐어 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 카딜라 핼쓰캐어 리미티드 filed Critical 카딜라 핼쓰캐어 리미티드
Publication of KR20120034606A publication Critical patent/KR20120034606A/ko
Application granted granted Critical
Publication of KR101451470B1 publication Critical patent/KR101451470B1/ko

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

본 발명은 부갑상선 호르몬(PTH/ PTH-1) 수용체 작용물질로서 주로 작용하는 다음의 화학식 1 의 신규한 단쇄 펩티드(short-chain peptide)를 제공한다. 이러한 단쇄 펩티드는 단백질 분해에 대해 증가된 안정성을 나타낸다. 대부분의 단쇄 펩티드는 (생체 외에서) 24 시간까지 안정적이었고, (생체 외에서) 랫 펩신 및 산성의 위 pH 와 같은 GIT 효소 및 간 마이크로솜에 대비하여 증가된 안정성을 나타냄을 발견하였다. 증가된 대사 안정성 때문에, 부갑상선 기능 저하증, 및 골다공증 및 폐경후 골다공증과 같은 골량 감소에 의해 특징지어지는 질병의 치료/예방 및 골 회복을 촉진시키기 위해 몇몇의 단쇄 펩티드를 비 경구 투여 외에 경구 투여할 수 있다.
화학식 1
A-Z1-Z2-Z3-Z4-Z5-Z6-Z7-Z8-Z9-Z10-Z11-Z12-Z13-Z14-Z15-B

Description

부갑상선호르몬(ＰＴＨ) 수용체 작용물질로서의 단쇄 펩티드{SHORT-CHAIN PEPTIDES AS PARATHYROID HORMONE(PTH) RECEPTOR AGONIST}
본 발명은 일반적인 화학식 1 의 PTH 수용체 작용물질로서의 신규한 단쇄 펩티드, 이의 약제학적으로 허용되는 염 및 이를 포함하는 약제학적 조성물에 관한 것이다.
화학식 1
A-Z1-Z2-Z3-Z4-Z5-Z6-Z7-Z8-Z9-Z10-Z11-Z12-Z13-Z14-Z15-B
본 발명은 또한 일반적인 화학식 1 의 화합물, 이의 약제학적으로 허용되는 염 및 이를 포함하는 약제학적 조성물을 제조하는 방법에 관한 것이다.
골다공증은 골량(bone mass), 골밀도(bone mineral density : BMD), 골강도(bone strength)의 감소에 의해 특징지어지거나 골절의 위험성을 증가시키는 것과 연관된 골격 질환이다.(Lane J. M. 등의, Clin. Orthop. Relat. Res., 372, 2000, 139-150). 대부분의 골다공증성 골절은 척추골, 고관절 또는 대퇴골에서 발생한다. 이러한 골절은 통증, 지속적인 부동 상태(long-lasting immobility)와 저조한 회복력 때문에 삶의 질을 심하게 손상시킨다. 골(bone)은 몇몇의 상이한 세포 유형을 포함한다. 조골세포(골 형성)는 세포 주위의 세포외 환경에 존재하는 미네랄로부터 새로운 골을 형성한다. 파골세포(osteoclast)(골 손실)는 세포외 메트릭스로 골 내에 구성된 미네랄을 방출하여 오래된 골을 제거한다. 충분한 새로운 골을 형성하는 것과 오래된 골을 제거하는 것 사이의 균형은 골에게 아주 유익한 특성을 주는 작용이다. 골다공증은 골을 형성하는 비율보다 골을 재흡수하는 비율이 클 때 발생한다(Seeman E. 등의, N. Engl. J. Med., 354(21), 2006, 2250-2261). 에스트로겐이 파골세포 수명을 변화시키기 때문에, 폐경 후 에스트로겐 결핍증은 여성에게 있어서 골다공증의 가장 일반적인 원인이다. 골다공증 진행에 있어서의 그 밖의 주요한 위험 요인은 저 칼슘 섭취, 비타민 D 결핍증, 제 1 형 당뇨병(type-1 diabetes), 류마티스 관절염, 항경련제 및 코르티코스테로이드류와 같은 양의 장기간 복용, 남성에게 있어서의 낮은 테스토스테론 농도를 포함한다(Cole Z. A. 등의 Curr. Rheumatol. Rep., 10(2), 2008, 92-96; Harvey, N.등의, Curr. Rheumatol. Rep., 5(1), 2003, 75-81).
골다공증을 가진 환자는 골절 회복을 촉진시키는 새로운 치료 또는 이러한 질병과 연관된 골절을 예방하거나 줄이는 치료로부터 이익을 볼 수 있다(Lindsay R., Lancet, 341(8848), 1993, 801-805). 현재는 에스트로겐, 랄록시펜(raloxifene)(에스트로겐 수용체 조절인자), 칼시토닌 및 비스포스포네이트(bisphosphonates)(에티드로네이트, 알렌드로네이트 및 리세드로네이트)가 이들의 골 재흡수 작용을 감소시킴으로써 이러한 질병의 치료에 다양한 수준의 성공률로 이러한 질병의 치료에 사용되고 있지만, 현재는 골다공증에 대한 효과적인 치유법은 없다(Recker R. R., J. Clin. Endocrinol. Metab., 1993, 76(1), 14-16).
천연의 인체(human) 부갑상선 호르몬(PTH)는 골과 신장에서 직접적인 작용을 통해서 인체에서 칼슘 항상성(calcium homeostasis)의 가장 주요한 조절인자로서 작용하는 84 아미노산 폴리펩티드이다(Kronenberg H. M., Bringhurst F. R., Nussbaum S. R., Jupner H., Abou-Samra A. B., In Handbook of Experimental Pharmacology, Mundy, G. R., and Martin, T. J., (eds), pp. 185-201, Springer-Verlag, Heidelberg (1993)). 갑상선으로부터 PTH 합성 및 방출은 혈청에서 주로 칼슘 농도를 조절한다 ; 낮은 농도에서는 호르몬의 합성과 방출을 자극하고 높은 농도에서는 호르몬의 합성과 방출을 억제한다. 결과적으로 PTH 는 혈액 내로 칼슘의 진입을 직접적으로 또는 간접적으로 촉진하여서 혈청에서의 칼슘 농도를 유지한다. PTH 는 비타민 D 의 활성형을 신장에서 합성하여 위장에서의 칼슘의 흡수에 기여한다. PTH 는 파골세포(골 재흡수 세포)의 분화를 간접적으로 자극하여서 골로부터 칼슘의 재흡수를 촉진시킨다. 비경구경로를 통한 PTH 의 투여는 골밀도(BMD), 골강도를 유효하게 증가시키고, 골다공증 환자에게 새로운 골다공성 골절의 발생을 감소시킨다(Greenspan S. L.등의, Ann. Intern. Med., 146(5), 2007, 326-339; Neer R. M., et al., N. Engl. J. Med., 344, 2001, 1434-1441).
PTH 는 수많은 조직, 가장 풍부하게 신장, 골 및 성장판 연골흡수세포에서 발현된 세포 표면 PTH 수용체와 이의 상호작용을 통하여 주로 이러한 모든 영향을 준다(Lanske B., et al., Crit. Rev. Eukaryot. Gene Expr., 8, 1998, 297-320). PTH 수용체는 세크레틴, 칼시토닌 및 글루카곤과 같은 펩티드 호르몬에 결합하는 수많은 다른 수용체와 일차구조와 유사하다 ; 이러한 수용체는 동시에 G-단백질 연결 수용체(G-protein coupled receptors : GPCR) 패밀리 B(family B) 라고 명명된 별개의 패밀리(distinct family)를 형성한다(Kolakowski L. F., Receptor Channels, 2, 1994, 1-7). GPCR 은 C-터미널 말단(C-terminal tail) 및 루프 사이에 오는 세븐 멤브레인-스패닝 α-헬릭스(seven membrane-spanning α-helices)의 막근접 도메인(juxtamembrane domain)(J-domain)에 연결되어 있는 100-160 잔기의 세포외 N-터미널 도메인을 포함한다(Donnelly D., FEBS Letts., 409, 1997, 431-436). 클래스 B(Class B) GPCRs 는 일반적으로 30-40 개의 아미노산인 중간 크기의 내인성 펩티드 리간드(endogenous peptide ligands)에 의해 활성화 된다(Hoare, S. R. J., Drug. Discovery Today, 10, 2005, 423-427). 클래스 B GPCRs 와 상호작용하는 펩티드 리간드의 일반적인 메커니즘은 알려졌고 흔히 '두 개의 도메인 모델(two-domain model)'라고 명명된다. 펩티드의 C-터미널 부분은 수용체의 N-도메인에 결합하고, 수용체에 리간드의 결합을 확인하고 N-터미널 리간드 영역은 J-도메인에 결합하고 이러한 상호작용은 수용체를 활성화시키고 세포내 신호전달(intracellular signaling)을 자극한다(Ji T. H.,등의, J. Biol. Chem., 273, 1988, 17299-17302; Hjorth, S. A. 등의, Regulatory Peptides, 64, 1996, 70).
PTH 는 nM 범위에서 친화력을 갖는 PTH 수용체에 결합한다 ; 리간드-결합 수용체(ligand-occupied receptor)는 이종삼합체(heterotrimeric) GTP-결합 단백질(G 단백질)을 매개자로 포함하는 매커니즘을 통해서 세포내 작동체 효소(effector enzyme)에 세포막을 가로질러 신호를 전달한다. PTH 펩티드에 반응하여 PTH 수용체에 의해 활성화된 일차 세포내 작용체 효소는 아데니닐시클라아제(adenylyl cyclase : AC)이다(Goltzman D., J. Bone Miner. Res., 15(3), 2000, 605-608). 따라서 PTH 는 골의 재형성(bone remolding)에 관여하는 저조하게 특징지어진 다운스트림 세포내 과정(downstream cellular processes)을 조절하는, 두번째 전달자로서 고리형 아데노신 모노포스페이트(cyclic adenosine monophosphate : cAMP)가 증가되도록 유도한다(Juppner H., et al., Science, 254, 1991, 1024-1026). 세포내 칼슘, 단백질 키나아제 C 의 포스포리파아제 C-의존적이고 독립적인 활성을 증가시키는 것과 같은 이러한 수용체의 또 다른 신호전달 과정은 기재되어 있다. PTH 가 혈액에서 칼슘 및 인산염 농도를 조절하고, 강력한 동화작용(골-형성) 효과를 나타내기 때문에, 부갑상선 호르몬 및 이의 유도체는 골다공증의 치료에 잠재적인 치료제로서 제시되고 있다(Slovik D. M. 등의, J. Bone Miner. Res., 1, 1986, 377-381; Dempster D. W. 등의 Endocr. Rev., 14, 1993, 690-709).
합성한 PTH(1-34)는 대부분의 세포-기반 검정 시스템(cell-based assay systems)에서 완전한 생체활성(bioactivity)를 나타내고, 동물의 골밀도에서 강한 동화작용을 가지고, 최근에는 폐경후 골다공성 여성에 있어서의 골절의 위험을 감소시키는 것으로 나타나고 있다. 페경후 여성에서의 인체실험에서, 저 농도의 PTH(1-34)를 매일 피하 주사한 결과, 척추 골절의 정도를 현저하게 감소시키면서 척추 및 대퇴골 경부에서의 인상적인 골 형성의 결과를 나타내었다(Neer R. M. 등의, N. Engl. J. Med., 344, 2001, 1434-1441; Dempster D. W. 등의, Endocr. Rev., 14, 1993, 690-709). 이러한 임상적 데이터는 골다공증에 대해서 실험한 가장 효과적인 인자 중의 하나가 PTH 임을 나타낸다. 상표명 Forteo(Eli Lilly)라는 이름으로 테리파라티드 아세테이트(teriparatide acetate) 형태의 PTH(1-34)는 골다공증의 치료제로 승인되었다.
PTH 유도체는 아미노산 치환체를 갖는 폴리펩티드를 포함하고, 완전한-길이의 분자(full-length molecule)에 비하여 길이가 줄었다. PTH(1-34)의 N과 C-터미널 둘다 절단된 형태는 연구되고 있다. 게다가 절단된 폴리펩티드 내에서의 아미노산 치환체는 또한 연구되고 있다(Azurani A.,등의, J. Biol. Chem., 271, 1996, 14931-14936). PTH 펩티드의 15-34 도메인에서의 잔기는 수용체 결합 친화력에 중요하게 기여하는 반면에, PTH 펩티드의 N-터미널 1-14 아미노산은 수용체의 활성에 기여하는 것으로 알려졌다(Naussbaum S. R.등의, J. Biol. Chem., 255, 1980, 10183-10187; Gardella T. J., 등의, Endocrinology, 132, 1993, 2024-2030; Takasu H., 등의, Biochemistry, 38, 1999, 13453-13460; Hoare S. R. J., 등의, J. Biol. Chem., 276, 2001, 7741-7753; Luck M. D., 등의, Molecular Endocrinology, 13, 1999, 670-680). 고리화(cyclised) PTH(1-17), PTH(1-28) 및 PTH(1-31)와 같은 절단된 PTH(1-34) 유도체는 대부분 검정 시스템에서 유효하고 골 형성을 증진시킨다(Whitfield J. F. 등의, J. Bone Miner. Res., 12, 1997, 1246-1252; WO 2007 / 130113 A2; WO 2008 / 068487; Whitefild J. F. 등의, Calcif. Tissue Int., 56, 1995, 227-231; Rixon R. H. 등의, J. Bone Miner. Res., 9, 1994, 1179-1189; Whitfield J. F. 등의, Trends Pharmacol. Sci., 16, 1995, 372-386; Whitfield J. F. 등의, Calcif. Tissue Int., 58, 1996, 81-87). 그러나 이러한 펩티드는 효율적으로 경구 투여하기에서 여전히 너무 크다. 보다 작은 PTH 작용물질의 발견은 골다공증에 대한 새로운 치료를 발전시킬 수 있는 중요한 진전이 될 것이다.
불행히도 PTH 펩티드의 큰 분자량으로 인하여 PTH 펩티드의 합성도 기술적으로 어렵고 따라서 비용도 많이 들어서 오직 가능한 투여 방법은 주사 경로(injection route)이기 때문에 PTH 펩티드의 치료상의 적용은 한정되어 있다. 게다가 PTH 는 프로테아제 공격에 매우 민감하여서, 이의 낮은 안정성 때문에 저온에서 저장해야 한다. 이러한 기술적인 한계뿐만 아니라, 독성데이터에서 나타나는 칼슘의 일시적인 부동화 및 고칼슘혈증으로 내약성(tolerability)이 제한되고, 특히 발암연구에서의 바람직하지 못한 결과(투여 및 치료의 기간에 따른 골육종의 위험의 증가)는 PTH(1-34)의 신중한 사용을 유도한다(Vahle J. L., Toxicol. Pathos., 32(4), 2004, 426-438; Whitfiel J. F., Medscape Womens Health, 6(5), 2001, 7; Kuijpers G., BMJ, 324(7335), 2002, 435-436). 반면에, 예를 들어 PTH 의 처음 14 개의 아미노산 PTH(1-14) 및 11개의 아미노산 PTH(1-11)으로 구성된 이러한 저분자량 펩티드는 동물 모델에서 불활성이거나 매우 낮은 생물학적 활성을 나타냄이 입증되었다(Tregear G. W. 등의, Endocrinology, 93, 1973, 1349-1353; Gardella T. J. 등의, J. Biol. Chem., 266, 1991, 13141-13146).
따라서, 지난 10년 동안 개선된 생물학적 프로파일(profile), 바람직하게 경구적으로 생체이용가능하고 프로테아제 저항성 있고 합성하기 쉽고 보다 높은 안전성 지표(safety index)를 갖는 PTH-유도된 저분자량 펩티드의 개발에 연구가 집중되고 있다. 최근에, 특정 부위에서의 나선 구조를 안정화시킨 비천연 아미노산을 도입함으로서 저분자량 펩티드의 활성도가 개선될 수 있음을 발견하였다. 예를 들어서 PTH(1-11) 유사체([Ala3, Gln10, Arg11]-PTH(1-11), [Ala3, Gln10, Har11]-PTH(1-11) 및 [Aib1 ,3; Gln10; Har11]-PTH(1-11)) 및 [AC5C1, Aib3, Gln10, Har11, Ala12, Trp14]PTH(1-14)과 같은 PTH(1-14) 유사체는 nM 범위에서 cAMP 를 활성화시킨다(WO 03/009804; WO 04/093902). PTH-유사 활성도를 갖는 저분자량 펩티드를 발견하기 위해 몇몇 실험들이 진행되고 있었다(Reidhaar-olson J. F.등의, Mol. Cell. Endocrinology., 160, 2000, 135-147; Shimizu M. 등의, J. Biol. Chem., 275, 2000, 21836-21843; Shimizu M. 등의, Endocrinology, 142, 2001, 3068-3074; Shimizu N.등의., J. Biol. Chem., 276, 2001, 49003-49012; WO 03/009804). 11 개 정도의 아미노산으로 구성된 짧은 유사체(처음 1-11 잔기의 PTH 펩티드 유사체, Seq. ID NO. 2)가 비록 (생체 외에서) 낮은 효력으로 PTH 수용체를 활성화시킬 수 있으나(WO 04/067021), 동물 모델(생체 내)에서 이러한 유사체의 골-동화작용(bone-anabolic activity)은 보고된 바 없다. 결론적으로, (생체 외에서) PTH 수용체의 cAMP-신호전달 경로(cAMP-signalling pathway)에서의 작용물질 활성도만으로는 생체 내에서 골-동화작용을 모두 예측할 수는 없다.
최근 연구에서, 비천연 아미노산을 갖는 N-터미널 서열(처음 1-14 또는 1-15 잔기, Seq ID. No. 3 및 4)의 PTH(1-34) 펩티드의 상동하는 치환체(유도체)가 다양한 정도의 분포도에서 강한 PTH 수용체 효능적 활성(agonistic activity), 보다 특이적으로 PTH-1 수용체 효능적 활성을 갖는 신규한 클래스의 단쇄 펩티드를 발견하는 결과를 가져옴을 우리는 놀랍게도 발견하게 되었다. 단백질 분해효소에 대항하여 작용과 안정성의 지속을 증진시키기 위해서, 우리는 비천연 아미노산을 갖는 부위-특이적으로 변형된 단쇄 펩티드(site-specifically modified the short-chain peptides)를 획득하였고 대사적으로 안정화되고 매우 효능이 강한 단쇄 펩티드를 식별하는데 성공하였다. 몇몇의 단쇄 펩티드는 경구 투여에서도 PTH-1 수용체 효능적 활성을 유지하면서 생물학적 이용도(bioavailability)를 나타내었다.
다음에 나타낸 PTH(1-34) 서열 배열은 1차 구조상의 관계를 나타낸다 ;
PTH (1-34): 1SVSEIQLMHNLGKH14LNSMERVEWLRKKLQDVHNF34 (Seq. ID No: 1) ;
PTH (1-11): 1SVSEIQLMHNL11 (Seq. ID No: 2) ;
PTH (1-14): 1SVSEIQLMHNLGKH14 (Seq. ID No: 3) ;
PTH (1-15): 1SVSEIQLMHNLGKHL15 (Seq. ID No: 4).
아미노산에 대한 단일문자 약자는 Zubay, G., Biochemistry 2nd ed., 1988, MacMillan Publishing, New York, p. 33 에서 찾을 수 있다.
선행기술
형태적으로 강요된 부갑상선 호르몬 펩티드(PTH) 유사체 및 유도체의 시리즈(series)는 일반적인 화학식 Xaa1-Xaa11 및/또는 Xaa1-Xaa14 로 알려졌다 ; 여기에서 몇몇 유사체와 함께 Xaa1-Xaa11 및/또는 Xaa1-Xaa14 는 PTH 펩티드의 처음 1-11 및/또는 1-14 N-터미널 잔기를 나타내고, Xaa1 및 Xaa3 는 Aib 또는 AC5C를 나타내고, Xaa8 은 Nle 를 나타내고 ; Xaa10 은 Q 를 나타내고, Xaa11 은 Har 를 나타내고, Xaa12 는 Ala를 나타내며 Xaa14는 W를 나타낸다(WO 03 / 009804 A2; US 2006 / 7153951 B2; US 2007 / 0117157 A1; US 2007 / 0203071 A1; US 2006 / 0019902 A1; US 2007 / 0161569 A1; US 2007 / 0111946 A1; Gardella T. J. 등의, J. Biol. Chem. 2000, 275, 21836-21843; Gardella T. J.등의, Endocrinology, 2001, 142, 3068-3074; Gardella T. J. 등의, J. Biol. Chem., 2001, 52, 49003-49012). 최근에 몇몇 비-펩티드 PTH 작용물질은 문헌에 또한 보고된 바가 있으나, 이들 중 어디에서도 생체 내 동물 모델에서의 잠재적인 가능성을 갖는 것으로 발견된 것은 없었다(US 2007 / 0099940 A1; WO 2005 / 077918 A1).
발명의 요약
본 발명은 PTH/PTH-1 수용체에 대해서 상이한 정도의 친화력을 갖고 골다공증 치료에 유용한, PTH 수용체의 작용물질로서 기능하는 신규한 단쇄 펩티드 그룹(group)에 관한 것이다. 이러한 단쇄 펩티드는 하기한 바와 같이 일반적인 화학식 1 에 나타내었다. 본 발명의 단쇄 펩티드는 부갑상선 기능 저하증, 및 골다공증, 폐경후 골다공증과 같은 골밀도 감소 또는 골 손실에 의해 특징지어지는 질병의 치료 또는 예방에 유용하고 골 회복(bone repair)에 유용하다.
본 발명은 주로 PTH/PTH-1 수용체 작용물질로서 작용하는 화학식 1 의 신규한 단쇄 펩티드를 제공한다. 이러한 단쇄 펩티드는 단백질 분해 효소에 대항하는 증가된 대사 안정성을 나타낸다. 대부분의 단쇄 펩티드는 (생체 외에서) 24 시간까지 랫 혈장에서 안정적이고, (생체 외에서) 펩신 및 산성의 위(stomach) pH 와 같은 GIT 효소 및 또한 간 마이크로솜(liver microsomes)에 대한 증가된 안정성을 나타내었다. 비경구 투여 외에 증가된 대사 안정성(metabolic stability) 때문에, 이러한 단쇄 펩티드 중 몇몇을 또한 경구투여로 전달할 수 있다.
바람직한 실시형태
본 발명의 바람직한 실시형태는 골 장애의 치료/경감/조절하기에 적절한, 일반적인 화학식 1 의 신규한 단쇄 펩티드, 이들의 합성과 관련된 신규한 매개자, 이들의 약제학적으로 허용되는 염 및 이들 또는 이들의 혼합물을 포함하는 약제학적 조성물에 관한 것이다.
보다 바람직한 실시형태에서, 본 발명은 일반적인 화학식 1 의 단쇄 펩티드, 이의 약제학적으로 허용되는 염, 용매화합물 및 약제학적으로 허용되는 담체, 용매화합물, 희석제, 부형제 및 이들의 제조과정에서 일반적으로 사용되는 그밖의 매체(media)를 갖는 이들 혼합물을 함유하는 약제학적 조성물을 제공한다.
보다 추가적으로 바람직한 실시형태에서, 본 발명은 화학식 1 의 단쇄 펩티드 또는 이들의 약제학적으로 허용되는 조성물을 이러한 치료를 필요로 하는 포유동물에게 독성을 나타내지 않는 약제학적으로 유효량을 투여하여, 골다공증 및 연관된 골 장애를 치료 및/또는 예방하고 새로운 골 형성을 촉진하는 제제로서의 본 발명의 신규한 단쇄 펩티드의 용도를 제공한다.
본 발명의 상세한 설명
본 발명에 따라, PTH-1 수용체 효능적 활성을 나타내는, 구조적인 화학식 1 을 갖는 합성된 단쇄 펩티드를 나타내었다. 대부분의 단쇄 펩티드는 (생체 외에서) 24시간까지 랫 혈장에서 안정적이고, (생체 외에서) 펩신 및 산성의 위(stomach) pH 와 같은 GIT 효소 및 또한 간 마이크로솜(liver microsomes)에 대한 증가된 안정성을 나타냄을 발견함으로써 이러한 단쇄 펩티드는 단백질 분해(proteolytic cleavage)에 대한 증가된 대사 안정성을 나타낸다. 대사 안정성의 증가로 인하여 이러한 단쇄 펩티드의 몇몇은 부갑상선 기능 저하증, 골다공증, 폐경후 골다공증과 같은 골량 감소로 특징지어지는 질병의 치료/예방 및 골 회복의 촉진을 위해, 경구 투여로 또한 전달될 수 있다.
따라서, 본 발명은 다음의 화학식 1 을 갖는 PTH 수용체 작용물질로서의 신규한 단쇄 펩티드를 나타낸다 ;
화학식 1
A-Z1-Z2-Z3-Z4-Z5-Z6-Z7-Z8-Z9-Z10-Z11-Z12-Z13-Z14-Z15-B
여기에서,
A 는 -NH-R1 또는 R3-CO-NH-기를 나타내고
여기에서
R1 은 수소, 비오틴, 임의로 치환된 선형 또는 가지형 (C1 -18) 알킬 사슬, 또는 피로글루탐산(Pyr), Pro(P), 알파-메틸-프롤린(αMe-P), Val(V), N-메틸-발린(NMe-V), 알파-메틸-발린(αMe-V), Lys(비오틴), Lys(알킬), Lys(아세틸)과 같은 적절한 아미노산을 나타내고 ;
R3 은 임의로 치환된 선형 또는 가지형 (C1 -18) 알킬 사슬, (C1-6)알콕시, (C3-C6)시클로알킬, 아릴, 헤테로아릴 또는 아릴알킬기 중에서 선택한 것이다.
바람직한 실시형태에서, 아릴기는 페닐, 나프틸, 인다닐, 플루오레닐 또는 비페닐 기 중에서 선택한 것이고 ; 헤테로아릴기는 피리딜, 티에닐, 푸릴, 이미다졸일, 벤조푸라닐기 중에서 선택한 것이고 ; 아릴알킬기는 명세서에 기재된 바와 같이 알킬기에 아릴기를 부착한 것이다.
B는 -COOR2, -CONHR2 또는 CH2OR2 을 나타내고, 여기에서 R2 는 H, 또는 Val(V), 알파-메틸-발린(αMe-V), Lys(비오틴), Lys(알킬), Lys(아세틸) 등과 같은 적절한 아미노산을 나타내고 ;
각각의 Z1, Z3 및 Z12 는 동일하거나 상이할 수 있으며, 독립적으로 Ser(S), 알파-메틸-세린(αMe-S), Val(V), 알파-메틸-발린(αMe-V), Pro(P), 알파-메틸-프롤린(αMe-P), Gly(G), Ala(A), α-아미노-이소부티르산(Aib), 1-아미노 시클로프로판 카르복실산(AC3C), 1-아미노-시클로펜탄카르복실산(AC5C), 1-아미노-시클로헥산카르복실산(AC6C)을 포함하는 기 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않은 아미노산을 나타내고 :
Z2는 Val(V) 또는 αMe-Val(αMe-V)을 나타내고 ;
각각의 Z4, Z6 및 Z10은 동일하거나 상이할 수 있으며, 독립적으로 Glu(E), 호모글루탐산(HoGlu), 2-아미노-4-시아노부탄산(Abu(CN)), Asp(D), Asn(N), Gln(Q), Aib 을 포함하는 기 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내고 ;
각각의 Z5, Z7 및 Z9 은 동일하거나 상이할 수 있으며, 독립적으로 Leu(L), Ile(I), Nle(노르류신), Nva(노르발린), HoLeu(호모류신), Abu(CN), His(H), Phe(F), 하기한 바와 같은 알파-메틸-페닐알라닌(-α-Me-Phe-), 알파-메틸-2-플루오로페닐알라닌(-α-Me-2F-Phe-) 또는 알파-메틸-2,6-디플루로페닐알라닌(-α-Me-2,6-F-Phe-) 또는 2-플루오로페닐알라닌(-2F-Phe-)기를 포함하는 기 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내고 ;
Figure 112011085977158-pct00001

Z8 은 Met, N-메틸-Met((NMe)M), 알파-메틸-Met(αMe-M), 알파-메틸-발린(αMe-V), Leu, Nle, N-메틸-Nle((NMe)Nle), 알파-메틸-노르류신(αMe-Nle), Nva, HoLeu, 에티오닌(EtMet), 셀레노메티오닌(SMet), Val 을 포함하는 기 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내고 ;
Z11 및 Z13 은 동일하거나 상이할 수 있으며, 독립적으로 Aib, Pro(P), αMe-Pro, 리신(K), 리신-비오틴(K(비오틴)), 리신(니트로)[K(NO2)], 아르기닌(R), 아르기닌(니트로)[(Arg(NO2)], 호모아르기닌(Har), 오르니틴(Orn), 오르니틴(니트로)[Orn(NO2)], 시트룰린(Cit), 호모시트룰린(HoCit), Phe(F), 알파-메틸-페닐알라닌(-α-Me-Phe-), 알파-메틸-2-플루오로페닐알라닌(-α-Me-2F-Phe-) 또는 알파-메틸-2,6-디플루로페닐알라닌(-α-Me-2,6-F-Phe-) 또는 2-플루오로페닐알라닌(-2F-Phe-)을 포함하는 기 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내고 ;
Z14 는 하기한 바와 같은 2'-에틸-4'-메톡시-비페닐알라닌(Bip(OMe)), α-메틸화 Bip(OMe)[αMe-Bip(OMe)], αMe-Trp, 알파-메틸-페닐알라닌(-α-Me-Phe-), 알파-메틸-2-플루오로페닐알라닌(-α-Me-2F-Phe-), 알파-메틸-2,6-디플루로페닐알라닌(-α-Me-2,6-F-Phe-) 또는 2-플루오로페닐알라닌(-2F-Phe-)을 포함하는 기 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내며 ;
Figure 112011085977158-pct00002

Z15 는 존재하거나 존재하지 않는다. Z15 가 존재할 때 2-아미노-5-페닐발레르산(APPA) 또는 2-아미노-2-메틸-5-페닐발레르산(α-Me-APPA)을 포함하는 기 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타낸다 ;
Figure 112011085977158-pct00003

본 발명의 실시형태에 있어서, 본 발명은 하기한 화학식 1의 변형된 PTH 유사체를 제공한다 ;
여기에서 A는 -NH-R1 또는 R3-CO-NH-기를 나타내고, R1 은 수소, 비오틴, 또는 피로글루탐산(Pyr), Pro(P), Val(V)과 같은 적절한 아미노산을 나타내고, 모든 부호는 하기에 나타낸 바와 같다 ;
본 발명의 또 다른 실시형태에 있어서, 본 발명은 R3 은 임의로 치환된 선형 또는 가지형 (C1 -18) 알킬 사슬로부터 선택한 화학식 1 의 화합물을 제공하고 모든 부호는 하기에 나타낸 바와 같다 ;
본 발명의 또 다른 실시형태에 있어서, 본 발명은 B 가 -COOR2, -CONHR2 를 나타내고, R2 는 H, 또는 Val(V), 알파-메틸-발린(αMe-V), Lys(비오틴)과 같은 적절한 아미노산을 나타내는 화학식 1 의 화합물을 제공하고 모든 부호는 하기에 나타낸 바와 같다 ;
본 발명의 또 다른 실시형태에 있어서, 본 발명은 화학식 1 의 화합물을 제공한다 ;
각각의 Z1, Z3 및 Z12 는 동일하거나 상이할 수 있으며, 독립적으로 Ala(A), α-아미노-이소부티르산(Aib), 1-아미노 시클로프로판 카르복실산(AC3C), 1-아미노-시클로펜탄카르복실산(AC5C), 1-아미노-시클로헥산카르복실산(AC6C)을 포함하는 기 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않은 아미노산을 나타내고 모든 부호는 하기에 나타낸 바와 같다.
본 발명의 또 다른 실시형태에 있어서, 본 발명은 다음의 화학식 1의 화합물을 제공한다 ;
Z2 는 Val(V)으로 구성된 기로부터 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않은 아미노산을 나타내고 모든 부호는 하기에 나타낸 바와 같다.
본 발명의 추가적인 실시형태에 있어서, 본 발명은 다음의 화학식 1 의 화합물을 제공한다 ;
각각의 Z4, Z6 및 Z10은 동일하거나 상이할 수 있으며, 독립적으로 Glu(E), Gln(Q), Aib 을 포함하는 기 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내고, 모든 부호는 하기에 나타낸 바와 같다.
본 발명의 또 다른 실시형태에 있어서, 본 발명은 다음의 화학식 1 의 화합물을 제공한다 ;
각각의 Z5, Z7 및 Z9 은 동일하거나 상이할 수 있으며, 독립적으로 Leu(L), Ile(I), Nle, HoLeu(호모류신), His(H), 알파-메틸-2-플루오로페닐알라닌(-α-Me-2F-Phe-) 또는 알파-메틸-2,6-디플루로페닐알라닌(-α-Me-2,6-F-Phe-)을 포함하는 기 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내고, 모든 부호는 하기에 나타낸 바와 같다 ;
본 발명의 또 다른 실시형태에 있어서, 본 발명은 다음의 화학식 1 의 화합물을 제공한다 ;
Z8 은 Met, 알파-메틸-Met(αMe-M), Nle, N-메틸-Nle((NMe)Nle)을 포함하는 기 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내고, 모든 부호는 하기에 나타낸 바와 같다.
본 발명의 또 다른 실시형태에 있어서, 본 발명은 다음의 화학식 1 의 화합물을 제공한다 ;
각각의 Z11 및 Z13 은 동일하거나 상이할 수 있으며, 독립적으로 Aib, αMe-Pro, 리신(K), 리신-비오틴(K(비오틴)), K(NO2), 아르기닌(R), Arg(NO2), 호모아르기닌(Har), 오르니틴(Orn), Orn(NO2), 시트룰린(Cit), 호모시트룰린(HoCit), 알파-메틸-2-플루오로페닐알라닌(-α-Me-2F-Phe-), 알파-메틸-2,6-디플루로페닐알라닌(-α-Me-2,6-F-Phe-)을 포함하는 기 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내고, 모든 부호는 하기에 나타낸 바와 같다.
본 발명의 또 다른 실시형태에 있어서, 본 발명은 다음의 화학식 1 의 화합물을 제공한다 ;
Z14 는 2'-에틸-4'-메톡시-비페닐알라닌(Bip(OMe)), α-메틸화 Bip(OMe)[αMe-Bip(OMe)], 알파-메틸-2-플루오로페닐알라닌(-α-Me-2F-Phe-), 알파-메틸-2,6-디플루로페닐알라닌(-α-Me-2,6-F-Phe-)을 포함하는 기 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내고, 모든 부호는 하기에 나타낸 바와 같다 ;
본 발명의 또 다른 실시형태에 있어서, 본 발명은 다음의 화학식 1 의 화합물을 제공한다 ;
Z15 는 존재하고, 2-아미노-5-페닐발레르산(APPA) 또는 2-아미노-2-메틸-5-페닐발레르산(α-Me-APPA)을 포함하는 기 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타낸다.
바람직한 실시형태에 있어서, 본 발명은 다음의 화학식 1 의 변형된 PTH 유사체를 나타낸다 ;
A 는 -NH-R1 또는 R3-CO-NH-기를 나타내고, 여기에서 R1 은 수소, 비오틴, 피로글루탐산(Pyr), Pro(P), Val(V)과 같은 적절한 아미노산을 나타내고 ; R3 은 임의로 치환된 선형 또는 가지형(C1 -18) 알킬 사슬로부터 선택한 것이고 ; B는 -COOR2, -CONHR2를 나타내고, 여기에서 R2 는 상기에 나타낸 바와 같고 ; 각각의 Z1, Z3 및 Z12 는 동일하거나 상이할 수 있으며, 독립적으로 Ala(A), α-아미노-이소부티르산(Aib), 1-아미노 시클로프로판 카르복실산(AC3C), 1-아미노-시클로펜탄카르복실산(AC5C), 1-아미노-시클로헥산카르복실산(AC6C)을 포함하는 기 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않은 아미노산을 나타내고 ; Z2 는 Val(V)을 나타내고 ; 각각의 Z4, Z6 및 Z10 은 동일하거나 상이할 수 있으며, 독립적으로 Glu(E), Gln(Q), Aib 을 포함하는 기 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내고 ; Z5, Z7 및 Z9 은 동일하거나 상이할 수 있으며, 독립적으로 Leu(L), Ile(I), Nle, HoLeu(호모류신), His(H), 알파-메틸-2-플루오로페닐알라닌(-α-Me-2F-Phe-), 알파-메틸-2,6-디플루로페닐알라닌(-α-Me-2,6-F-Phe-)을 포함하는 기 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내고 ; Z8 은 Met, 알파-메틸-Met(αMe-M), Nle, N-메틸-Nle((NMe)Nle)을 포함하는 기 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내고 ; Z11 및 Z13 은 동일하거나 상이할 수 있으며, 독립적으로 Aib, αMe-Pro, 리신(K), 리신-비오틴(K(비오틴)), K(NO2), 아르기닌(R), Arg(NO2), 호모아르기닌(Har), 오르니틴(Orn), Orn(NO2), 시트룰린(Cit), 호모시트룰린(HoCit), 알파-메틸-2-플루오로페닐알라닌(-α-Me-2F-Phe-), 알파-메틸-2,6-디플루로페닐알라닌(-α-Me-2,6-F-Phe-)을 포함하는 기 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내고 ; Z14 는 2'-에틸-4'-메톡시-비페닐알라닌(Bip(OMe)), α-메틸화 Bip(OMe)[αMe-Bip(OMe)], 알파-메틸-2-플루오로페닐알라닌(-α-Me-2F-Phe-), 알파-메틸-2,6-디플루로페닐알라닌(-α-Me-2,6-F-Phe-)을 포함하는 기 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내며 ; Z15 가 존재할 때, Z15 는 2-아미노-5-페닐발레르산(APPA) 또는 2-아미노-2-메틸-5-페닐발레르산(α-Me-APPA)을 포함하는 기 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타낸다.
상기에 나타낸 기 중에서 치환기는 히드록시, 옥소, 할로, 티오(thio), 니트로, 아미노, 알킬, 알콕시, 할로알킬 또는 할로알콕시기 중에서 선택한 것이다.
용어 '천연 아미노산(natural amino acid)' 은 자연에 존재하는 모든 20 가지 아미노산을 나타낸다.
용어 '비천연 아미노산(unnatural amino acid 또는 non-natural amino acid 아미노산)'은 바람직하게 L-Ala 가 D-Ala 로 교체되는 것과 같이 L-아미노산이 이에 상응하는 D-아미노산으로 교체되거나, 다음의 a 또는 b 에 의한 L 또는 D 아미노산, 아미노 알킬 산(amino alkyl acids)의 적절한 변형물을 나타낸다 ;
a) Ala 이 α-메틸 Ala(Aib)로 치환되거나, Met가 α-메틸 Met 로 교체되는 것과 같은 α-알킬화 반응 ; 또는
b) 할로겐, (C1-C3)알킬, 아릴기를 갖는 방향족 아미노산 곁사슬로 치환되거나, 보다 특이적으로 Phe이 할로 Phe(halo Phe)로 교체되는 것과 같이 아미노산의 잔기의 치환.
본원의 명세서에 기재된 다양한 기, 라디칼 및 치환기는 다음의 단락에 기재하였다.
본원에서 기재된, 단독으로 또는 다른 라디칼과 결합된 용어 '알킬' 은 메틸, 에틸, n-프로필, 이소-프로필, n-부틸, sec-부틸, tert-부틸, 아밀, t-아밀, n-펜틸, n-헥실, iso-헥실, 헵틸, 옥틸, 데실, 테트라데실, 옥타데실 등과 같은 1 내지 8 의 탄소를 함유하는 선형 또는 가지형 라디칼을 나타낸다.
본원에 기재된, 단독으로 또는 다른 라디칼과 결합된 용어 '시클로알킬' 은 시클로프로필, 시클로부틸, 시클로펜틸, 시클로헥실, 시클로헵틸 등과 같은 3 내지 7 의 탄소를 함유하는 라디칼을 나타낸다.
다른 방법으로 나타내지 않는 한, 본원에서 단독으로 또는 다른 기의 부분으로 사용된 용어 '아미노산' 은 제한없이 아미노기 및 'α' 탄소로 언급된 동일한 탄소에 연결된 카르복실기를 포함한다.
'α' 탄소에서의 완전한 'S' 입체배치는 'L' 또는 천연의 입체배치로서 일반적으로 나타낸다. 'α' 탄소에서의 'R' 입체배치는 'D' 아미노산으로 일반적으로 나타내었다. 수소 또는 메틸과 같이 'α-치환기'가 둘 다 동일한 경우에는 아미노산은 Gly 또는 Aib 이고, 비대칭이 아니다.
본 발명은 단쇄 펩티드에 관하여 주로 예를 들었지만, PTH 효능적 활성을 모방할 수 있는 능력을 유지할 수 있다면 잔기 사이의 펩티드 결합은 비-펩티드 결합으로 교체될 수 있음을 또한 이해할 수 있을 것이다. 본 분야의 숙련자는 티오아미드 결합 형성, 아미드 결합의 N-메틸화 등과 같은 적절한 변형물을 인지할 수 있다.
생물학적 활성도가 유지된다면, 아미노산의 보존성 치환을 포함하는 서열은 또한 본 발명의 범위 내에 속한다.
본 발명의 화합물은 다음으로 한정되지 않지만 이를 포함하는 펩티드 아미드 및 비-아미드 및 펩티드 유사체를 포함함을 분명하게 이해할 수 있을 것이다 ;
a) 하나 또는 그 이상의 아미노산이 이에 상응하는 D-아미노산으로 교체된 화합물. 본 분야의 숙련자는 레트로-인버소 아미노산 서열(retro-inverso amino acid sequences)을 표준실험 방법으로 합성할 수 있음을 인식할 수 있을 것이다 ; 예를 들어 Chorev M., Acc. Chem. Res., 26, 1993, 266-273 참조 ;
b) 펩티드 결합이 대사적인 분해에 보다 잘 견딜 수 있는 구조로 교체된 펩티드 모방성 화합물(peptidomimetic compound). 예를 들어 Olson G. L., et al., J. Med. Chem., 36(21), 1993, 3039-3049 참조 ; 및
c) 예를 들어 Ala 가 Aib 로 또는 Met 가 α-Me-Met 로 교체된 것과 같이 각각의 아미노산이 유사한 구조로 교체된 화합물.
일반적으로, 이러한 교체 가능한 구조물의 사용은, 이들이 생리학적 조건 하에서 분해에 보다 저항성을 갖거나 또는 생물학적 이용도를 증진시키기 때문에 신체에서 상당히 긴 반감기를 제공할 수 있다.
상세한 설명에 기재된 천연 아미노산의 일반적인 하나의 문자 코드 및 세 문자 코드는 Har(호모아르기닌), Nle(노르류신), α-아미노 이소부티르산(Aib)으로 사용된 바와 같이 다른 비천연 아미노산의 세 문자 코드에서도 일반적으로 허용가능하게 사용할 수 있다.
용어 'PTH 수용체 조절인자 또는 작용물질'은 PTH-1 및/또는 PTH-2 수용체에서 cAMP 생산과 같이 하위 신호전달(downstream signaling event)을 조절할 수 있는 PTH-1 및/또는 PTH-2 수용체의 능력을 변화시키도록 작용할 수 있는 화합물을 나타낸다. 수용체 조절인자의 예로서 작용물질, 부분적인 작용물질, 반대 작용물질(inverse agonist) 및 알로스테릭 강화제(allosteric potentiator)를 포함한다.
본 발명에 따라서, 본원에 기재된 합성된 분리된(isolated) 단쇄 펩티드는 주로 PTH 수용체 작용물질로서 작용한다. 이러한 합성된 단쇄 펩티드는 생체외에서 1-1000 nM 농도의 범위로 UMR-106 세포에서 생체 외 바람직한 PTH 수용체의 효능적 활성을 나타내었다. PTH 수용체의 효능적 활성은 실험 화합물에 의해 방출된 cAMP 의 양을 평가하여 측정하였다. 몇몇의 제조된 단쇄 펩티드는 생체내 OVX 랫 모델에서 실험하였을 때 BMD 및/또는 골 강도에서의 증가를 나타내었고, 따라서 이들 펩티드는 골다공증의 치료 및 예방에 이상적인 치료학적 후보물질이 될 수 있다. 이러한 새로운 클래스(class)의 단쇄 펩티드는 경구 또는 그밖의 비외과적인 경로(non-invasive routes) 또는 비경구의 투여 방법에 의해 투여될 수 있다.
본 발명은 이러한 단쇄 펩티드가 단독으로 또는 조합물(combination)로서 사용된 화학식 1 의 약제학적 조성물 및 이러한 단쇄 펩티드를 사용하는 방법을 제공한다. 특히, 본 발명은 약제학적으로 허용되는 담체와 화학식 1 의 단쇄 펩티드를 단독으로 또는 조합물로 약제학적 유효량을 포함하는 약제학적 조성물을 제공한다. 게다가 본 발명은 화학식 1 의 단쇄 펩티드 또는 이들의 조합물의 약제학적 유효량을 치료를 필요로 하는 포유동물, 예를 들어 인체 및 환자에게 투여하여, 골다공증, 특히 초기 골다공증, 내분비성 골다공증(endocrine osteoporosis), 폐경후 골다공증, 유전적이고 선천적인 형태의 골다공증의 진행 또는 발현을 치료하거나 지연시키는 방법을 제공한다.
단쇄 펩티드의 제조방법 :
본 발명의 단쇄 펩티드를 제조하기 위해서 펩티드 합성 분야에서 숙련된 숙련자에게 공지된 몇몇의 합성 방법을 사용할 수 있다. 모든 부호는 하기에 나타낸 바와 같은 화학식 1 의 단쇄 펩티드는 펩티드 합성 분야에서 숙련자에게 공지된 일반적인 방법 또는 본 분야의 숙련자에 의해서 예측될 수 있는 변형된 방법과 함께 하기에 나타낸 방법을 사용하여서 합성할 수 있다. 언급된 방법은 하기에 나타낸 방법을 포함하지만 이로 한정되지 않는다.
본원에 기재된 이의 단쇄 펩티드는 G. Barany & R. B. Merrifield "The peptides: Analysis, synthesis, Biology" ; Volume 2- "Special methods in peptide synthesis, Part A", pp. 3-284, E. Gross & J. Meienhofer, Eds., Academic Press, New York, 1980; and in J. M. Stewart and J. D. Young, "Solid-phase peptide synthesis" 2nd Ed., Pierce chemical Co., Rockford, Il, 1984. 에 기재된 바와 같이 용액상(solution-phase)(바람직하게, Boc-화학 ; M. Bodansky, A. Bodansky, "The practice of peptide synthesis", Springer-Verlag, Berlim, 1984; E. Gross, J. Meinhofer, "The peptide synthesis, analysis, biology", Vol. 1, Academic Press, London, 1979) 및/또는 고체상 기술 둘 다의 적절한 변형된 방법을 사용하여 화학적 합성에 의해 생산될 수 있다.
본 발명의 단쇄 펩티드를 제조하기 위한 바람직한 방법은 Fmoc-기반 SPPS 처리방법을 사용을 기반으로 하며, 여기에서 만약 존재한다면 아미노산 잔기의 일시적인 보호를 위해서, tert-부톡시카르보닐(Boc), tert-부틸(But), 트리틸(Trt)기(도 2)와 같은 산성 이치환성 보호기(acid labile protecting groups)가 결합된 Fmoc(9-플루오레닐메톡시카르보닐)기를 사용하였다(예를 들어 E. Atherton & R.C. Sheppard, "The Fluorenylmethoxycarbonyl amino protecting group", in "The peptides: Analysis, synthesis, Biology"; Volume 9 - "Special methods in peptide synthesis, Part C", pp. 1-38, S. Undenfriend & J. Meienhofer, Eds., Academic Press, San Diego, 1987 를 참고).
단쇄 펩티드를 펩티드의 C-터미널 형태로 시작되는 불수용성 폴리머 지지체(수지 : resin)로 순차적인 방법으로 합성할 수 있다. 실시형태에 있어서, 합성은 아미드, 에스테르 또는 에테르 결합의 형성을 통해서 수지에 펩티드의 C-터미널 아미노산을 결합시켜서 시작된다. 이는 각각 C-터미널 아미드, 카르복실산 또는 알콜과 같은 결과적으로 발생한 펩티드의 최종적인 방출을 가능하게 한다.
Fmoc-기반 SPPS 에서, 수지로부터 펩티드의 때이른 분해 또는 곁사슬 보호기의 탈보호 없이, 20 % 피페리딘 용액과 같은 적절한 염기를 사용하여 α-아미노 보호기가 합성되는 동안에 선택적으로 제거될 수 있는 것과 같이 이러한 합성에서 사용된 C-터미널 아미노산 및 그 밖의 아미노산은 (만약 존재한다면) 별도로 보호된(직교의 보호 : orthogonal protection) 이들의 α-아미노기 및 곁사슬 기능을 가져야 하고 산성 이치환성 보호기로 일반적으로 보호되어야 한다.
아미노산의 결합은 수지에 부착된 N-터미널 아미노산의 비블럭화 된(unblocked) α-아미노기로 활성 에스테르 및 이의 반응으로써 이의 카르복실기의 활성에 의해서 실시된다. 모든 결합 및 탈보호 반응 후에는 펩티딜-수지는 DMF, DCM 및 디에틸 에테르와 같은 초과량의 용액으로 세척하였다. α-아미노산 기의 탈보호 및 결합의 연속된 과정을 바람직한 펩티드 서열이 조립될 때까지 반복한다(도식 1). 그리고 난 다음에 부가 반응(side reaction)을 제한하기 위해서 일반적으로 적절한 스캐빈져(scavenger)의 존재 하에서 적절한 분해 혼합물을 사용하여 곁사슬 기능에 수반되는 탈보호를 갖는 수지로부터 펩티드를 분해하였다. 결과적으로 생성된 펩티드를 역상 HPLC 로 최종적으로 정제하였다.
최종 펩티드에 대한 전구체(precursor)로서 요구된 펩티딜-수지의 합성물은 상업적으로 이용가능한 교차-결합된 폴리스티렌 폴리머 수지(미국 캘리포니아 샌디에고 Novabiochem)를 활용하였다. 본 발명에서 C-터미널 아미노산을 이미 부착되었거나 부착되지 않은 Fmoc-PAL-PEG-PS 수지, 4-(2',4'-디메톡시페닐-Fmoc-아미노메틸)-페녹시아세틸-p-메틸 벤즈하이드릴아민 수지(Fmoc-Rink 아미드 MBHA 수지), 2-클로로-트리틸-클로라이드 수지 또는 p-벤질옥시벤질 알콜 수지(HMP 수지)를 우선적으로 사용하였다. C-터미널 아미노산이 부착되지 않았다면, DIPCDI로 이러한 반응으로 형성된 Fmoc-보호된 아미노산의 HOBt 활성 에스테르에 의해서 부착시킬 수 있다. 2-클로로-트리틸 수지의 경우에는, DIPEA를 사용하여 첫번째 Fmoc-보호된 아미노산을 결합시켰다. 다음의 아미노산 조합을 위해서 펩티딜 수지의 N-터미널 보호는 10-20% 피페리딘 용액을 사용하여 선택적으로 탈보호되었다. 모든 결합 및 탈보호반응 후에, 아미노산 및 결합 시약의 잉여물을 DMF, DCM 및 에테르로 세척하여 제거하였다. 각각의 DIPCDI/HOBt 또는 DIPCDI/HOAT 로부터 생성된 HOBt 또는 HOAT 활성 에스테르를 사용하여 다음의 아미노산의 결합을 성취할 수 있었다. 특히 소수성 아미노산 또는 부피가 큰(bulky) 곁사슬 보호기를 가진 아미노산의 몇몇의 어려운 결합의 경우에는, DIPEA 와 같은 첨가물과 함께 HBTU, PyBOP 또는 TBTU 와 같은 매우 효율적인 결합제를 사용하여서 결합을 완전하게 달성할 수 있다.
본원에 기재된 단쇄 펩티드의 합성은 Fmoc/t-부틸 보호 방법을 활용하여 CS-Bio 또는 AAPPTEC 펩티드 합성장치(synthesizer)와 같은 회분식(batchwise) 또는 연속식 펩티드 합성 장치(continuous flow peptide synthesis apparatus)를 사용하여서 실행할 수 있다. 상이한 위치에서 존재하는 비-천연의 상업적이지 않은 아미노산을 본 분야에서 공지된 하나 또는 그 이상의 방법을 사용하여 펩티드 사슬에 결합시켰다. 하나의 처리방법에 있어서, 적절한 문헌의 절차를 사용하여 Fmoc-보호된 비-천연 아미노산을 용액에서 제조하였다. 예를 들어서, 문헌의 변형된 절차를 사용하여 좋은 거울상 이성질체 순도로 L-피로글루탐삼으로부터 상기에 기재한 Fmoc-보호된 APPA 유사체를 제조하였다(Betsbrugge J.V.등의, Tetrahedron, 54, 1988, 1753-1762).
비대칭성 스트레이터 합성방법(asymmetric Strecker synthesis)을 사용하여 Fmoc-보호된 α-메틸화 아미노산을 제조하였다(Boesten, W.H.J., et al., Org. Lett., 3(8), 2001, 1121-1124; Cativiela C., Diaz-de-villegas M. D., Tetrahedran Asymmetry, 9, 1988, 3517-3599). 그리고 난 다음에 결과적으로 생성된 유도체를 펩티드의 순차적인 합성에서 사용하였다. 그 대신에, 합성 유기화학 제조방법을 사용하여서 직접적으로 수지에 요구된 비-천연 아미노산을 합성하였고, 선형 펩티드 사슬을 합성하였다.
문헌에 기재된 표준 분해 절차에서의 적절한 변이(variation)를 사용하여 이들 각각의 단쇄 펩티드에 대한 펩티드-수지 전구체를 분해하고 탈보호시킬 수 있다(King D.S.,등의, Int. J. Peptide Protein Res., 1990, 36, 255-266). 본 발명에 사용된 바람직한 방법은 스캐빈져로서 물 및 TIPS의 존재 하에서 TFA 분해 혼합물을 사용하였다. 일반적으로, 펩티딜-수지를 실온에서 1.5-4 시간 동안 TFA/물/TIPS(95:2.5:2.5)에서 배양하였다(incubate). 그리고 난 다음에 분해된 수지를 여과하여 제거하고 환산압력 하에서 TFA 용액을 농축시키고 건조시켰다. 결과적으로 생성된 조 펩티드(crude peptide)를 침전시키거나 Et2O 로 세척하거나, 조제용(preparative) HPLC로 정제하기 위해 DMF 또는 50 % 수성 아세트산에 직접적으로 재용해시켰다.
원하는 순도를 갖는 단쇄 펩티드를 조제용 HPLC를 사용하여 정제하여 수득할 수 있다. 조 펩티드 용액을 semi-Prep 컬럼(Luna 10m; C18; 100 A), 치수 250 X 50 mm)에 주입시켰고, 용출액을 220 nm 로 PDA 검출기로 모니터하면서 40 mL/분의 유량으로 둘 다 0.1% 의 TFA 에 완충시킨 물에 용해시킨 ACN 의 선형 구배(linear gradient)로 용출시켰다. 정제된 단쇄 펩티드의 구조는 전기 스프레이 질량 분석기(Electrospray Mass Spectroscopy : ES-MS) 분석으로 확인할 수 있다.
제조된 모든 펩티드는 Prep-HPLC 정제 후에 반대이온(counter ion)으로서 TFA 와 함께 트리플루오로-아세테이트 염으로서 분리하였다. 그러나 적절한 이온 교환 수지 베드, 바람직하게 음이온-교환 수지 Dowex SBR P(Cl) 또는 당량 기초 음이온-교환 수지를 통해 통과시켜서 몇몇의 펩티드를 탈염시키기 위해 주입하였다. 몇몇의 경우에, 희석된 아세트산 완충용액으로 용출시켜 적절한 이온-교환 수지를 통과시킴으로써 TFA 반대이온을 아세테이트 이온으로 교체시켰다. 펩티드의 히드로클로라이드 염 제조를 위해서, 제조방법의 마지막 단계에서, 아세테이트 염을 갖는 선별된 펩티드를 4M HCl로 처리하였다. 결과적으로 생성된 용액을 막 필터(0.2 ㎛)으로 여과시키고 그 다음에 백색 내지 오프 화이트(off-white)의 HCL 염을 수득하기 위해서 동결건조시켰다. 본 분야에서의 숙련자에게 잘 알려진 범위 내에서 다음의 유사한 기술 및/또는 이러한 적절한 변형된 방법으로 본 발명의 단쇄 펩티드의 또 다른 적절한 약제학적으로 허용되는 염을 제조하였다.
도 1 : 랫 PTH-1 R 검정에서의 생체 외에서의 PTH(1-34) (A) 및 Seq. ID No. 111 (B)의 DRC 및 EC50 측정(방출된 cAMP 의 양으로 측정된 효능적 활성)
도 2 : 단쇄 펩티드의 Fmoc 기반-고체상 펩티드합성(SPPS)에서 사용된 직교하여 보호된 아미노산의 예
도 3 : OVX 암컷 랫의 생체 내에서 Seq. ID No. 111 (A : 혈청 Ca2 + 농도의 증가율 ; B: 혈청 PO4 농도의 감소율 %)
도 4 : Seq. ID No. 111 및 PTH(1-34)로 6 주 치료한 후의 OVX랫에서의 생화학적 파라미터 및 대퇴골 무게의 변화
도 5 : Seq. ID No. 111 로 6 주 치료한 후의 OVX 랫에서의 대퇴골 조직학적 단면도
도 6 : Seq. ID No. 111 로 6 주 치료한 후의 OVX 랫에서의 경골 조직학적 단면도
도 7 : Seq. ID No. 111 로 6 주 치료한 후의 OVX 랫에서의 요추 조직학적 단면도
SPPS 처리 방법을 사용한 단쇄 펩티드의 일반적인 제조방법 :
수지에서의 단쇄 펩티드의 조립 :
충분한 양(50-100mg)의 Fmoc-PAL-PEG-PS 수지 또는 Fmoc-Rink 아미드 MBHA 수지를 0.5-0.6 mmol/g 으로 로딩(loading)하여 2-10분 동안 DMF(1-10 mL /100 mg 의 수지)에서 부풀렸다. DMF(10-30mL/100mg의 수지)에 용해시킨 10-30% 피페리딘으로 수지를 10-30분 동안 배양하여 수지에서 Fmoc-기를 제거하였다. 탈보호된 수지를 여과시키고 초과량의 DMF, DCM 및 에테르(50 ml X 4)로 세척하였다. 질소 대기 하에서 세척된 수지를 5분 동안 갓 증류된 DMF(1 mL / 100 mg 의 수지)에서 배양시켰다. DMF에 용해시킨 0.5 M 용액의 첫번째 Fmoc-보호된 아미노산(1-3 eq.), 예비 활성화된 HOBt(1-3 eq.) 및 DIPCDI(1-2 eq.)를 수지에 첨가하고 질소 대기 하에서 수지를 1-3시간 동안 교반시켰다. 정성 닌하이드린 시험(qualitative ninhydrin test)를 이용하여 결합의 완성을 모니터하였다. 첫 번째 아미노산을 결합시킨 후에, 수지를 DMF, DCM 및 디에틸 에테르(50 mL X 4)로 세척하였다. 다음의 아미노산의 결합을 위해서, 다음에 상기에 기재한 바와 같이 우선 10-20% 피페리딘 용액을 이용하여 수지와 결합된 첫번째 아미노산에서의 Fmoc-보호를 탈보호시킨 적절한 결합제를 사용하여서 Fmoc-보호된 두 번째 아미노산을 결합시켰다.
일반적인 도식 1과 같이 수지에서의 원하는 펩티드 잔기를 조립할 때까지 탈보호, 세척, 결합 및 세척의 반복된 사이클을 실행하였다. 최종적으로 상기한 바와 같은 20% 피페리딘 처리에 의해서 상기에 제조된 Fmoc-보호된 펩티딜-수지를 탈보호시켰고, 펩티딜-수지를 DMF, DCM 및 디에틸 에테르(50 mL X 4)로 세척하였다. 원하는 펩티드를 포함하는 수지를 질소 압력 하에서 10-15 분 동안 건조시키고 분해/탈보호시키기 위해 주입시켰다.
본 분야의 숙련자에게 알려진 범위 내에서 상기의 프로토콜 및 이의 적절한 변형방법을 사용하여, Fmoc-SPPS 처리 방법을 사용하여 본 발명에서 의도된 단쇄 펩티드를 제조하였다. 최종적으로, 단쇄 펩티드가 결합된 수지를 분해하고 탈보호시키고 다음의 부분에 기재된 프로토콜을 이용하여 정제하고 특징지었다.
펩티드 서열 ID . No . 18 의 자동화된 고체상 합성의 대표적인 예 : H 2 N -(AC 5 C)-V-(AC 5 C)-EIQLMHQ-Har-(α Me - Pro )-K-(α- Me - Phe )- CONH 2 .
선형의 단쇄 펩티드 H2N-(AC5C)-V-(AC5C)-EIQLMHQ-Har-(αMe-Pro)-K-(α-Me-Phe)-PAL-PEG-PS 를 Fmoc 고체상 펩티드 합성(SPPS) 처리방법(도식 2)을 사용하여 자동화된 CS-Bio 536 PepSynthesiserTM 에서 조립하였다. Fmoc 아미노산 및 2-(1H-벤조트리아졸-1-일)-1,1,3,3-테트라메틸우로늄테트라플루오로보레이트(TBTU)를 우리병에 넣어서 같이 포장하고, 합성장치의 아미노산 모듈(module)에 두었다.
Figure 112011085977158-pct00004

디이소프로필에틸아민(DIPEA ; 0.9 M) 및 DMF 의 원액(stock solution)을 건조 질소 대기 하에서 시약병에 보관처리하다. 수지 Fmoc-PAL-PEG-PS(0.38 mmol/g; 1g)를 (1 시간) 진공에서 P2O5 상에서 건조시키고, 갓 증류된 DMF(5 mL)에서 부풀렸다. 부풀어진 수지를 유리컬럼(glass column)에 슬러리(slurry)상태로 보관처리 하였고 합성 장치에 두었다. 모든 합성 사이클을 표 1 에 나타낸 바와 같이 5 mL min-1의 유량으로 실시하였다. 수지를 10 분 동안 갓 증류된 DMF 로 세척하였다. Fmoc기의 탈보호를 10 분 동안 DMF 에 용해시킨 20 % 피페리딘으로 실행하고, 탈보호 여부를 304 nm 에서 컬럼 용출액의 UV 검출로 모니터하였다.
[표 1]
고체상 펩티드 합성의 자동화된 사이클
Figure 112011085977158-pct00005

각각의 사이클 당 15 분으로 3 번의 보조 세척 사이클 및 증류된 DMF 세척 사이클로 과량의 피페리딘을 제거하였다. 아미노기를 Fmoc-아미노산(4 당량)으로 처리하고, DIPEA(8 당량)의 존재 하에서 TBTU(3.9 당량)으로 미리 활성화시키고 120 분 동안 재순환시켰다. 각각의 사이클에서 10 분 동안 4 번의 보조 세척 사이클 및 증류된 DMF 세척 사이클을 통해 컬럼 및 루프로부터 과량의 아미노산 및 수용성 부산물을 제거하였다. 더욱이, 선형 펩티드의 완전한 조립을 위해서 합성 사이클(탈보호, 세척, 아실화 및 세척)을 반복하였다. 터미널 Fmoc기를 제거하기 위해서 15 분 동안 DMF 에 용해시킨 20 % 피페리딘으로 최종적인 탈보호 사이클을 실시하고 세척 사이클(10 X 4 분)을 실시하였다. 완전한 펩티드-수지를 소결 유리 여과기(sintered glass filter)로 정제하고, DMF, DCM, 메탄올, DMF 및 디에틸 에테르(각각 100 mL)로 연속적으로 3 번 세척하였다. P2O5 (2 hr) 상 진공에서 펩티드-수지를 건조시키고 -20 ℃ 에서 저장하였다.
Figure 112011085977158-pct00006

도식 2 : Seq . ID . No . 18 의 SPPS
수지 결합된 펩티드의 N-터미널 유리 아미노기를 확인하기 위해서 닌하이드린 시험을 실시하였다. 남색의 용액 및 수지 비드(bead)의 출현은 수지에서 유리 아미노기의 존재를 나타내고 양성 반응(positive test)로 간주된다.
수지 결합된 펩티드의 순도를 측정하기 위해서 소규모 분해를 실시하였다. 실온에서 90 분 동안 서서히 가끔씩 저어주면서 건조된 펩티드-수지(ca 10-mg)를 TFA, 물, 트리이소프로필실란(95: 2.5: 2.5 v/v)의 혼합물(1 mL)로 처리하였다. 수지를 정제하고 아무것도 섞지 않은 TFA(1 mL)로 철저히 세척하고, 전체 여과액을 환산 압력 하에서 증발시켰다. 잔류한 TFA 를 디에틸 에테르(2 mL)로 3 번 공비혼합 시켰다. 수득한 잔류물을 증류수(2 mL)에 현탁시키고 수성층을 디에틸 에테르(3 mL)로 3 번 추출하였다. 조펩티드 H2N-(AC5C)-V-(AC5C)-EIQLMHQ-Har-(αMe-Pro)-K-(α-Me-Phe)-CONH2 를 산출하기 위해서 수성층을 분리하고 동결건조시켰다. 동결건조된 펩티드 H2N-(AC5C)-V-(AC5C)-EIQLMHQ-Har-(αMe-Pro)-K-(α-Me-Phe)-CONH2 를 0.1 % 수성 TFA(ca 1mg /1 mL)에 용해시키고 이의 순도를 RP-HPLC 로 분석하였고 전기 스프레이 이온화 질량 분석법(ESI-MS)으로 특징지었다. 순도 퍼센트 : 90 %(조 펩티드). ESI-MS; H2N-(AC5C)-V-(AC5C)-EIQLMHQ-Har-(αMe-Pro)-K-(α-Me-Phe)-CONH2 에 대한 계산치: 1790 (M+), 1812 (M+Na+) 및 1828 (M+K+); 측정치 (m/z): 1790 (M+), 1812 (M+Na+) and 1828 (M+K+).
본 분야의 숙련자의 범위 내에서 상기의 프로토콜 및 이의 적절한 변형 방법을 사용하여, Fmoc-SPPS 처리방법을 사용하여 본 발명의 원하는 단쇄 펩티드를 제조하였다. 더욱이, 하기의 프로토콜을 사용하여 수지 결합된 단쇄 펩티드를 분해하고 탈보호하고 정제하고 특징지었다.
분해 및 탈보호 :
원하는 단쇄 펩티드를 다음과 같이 TFA 분해 혼합물로 처리하여 이들 각각의 펩티딜-수지로부터 분해하고 탈보호시켰다. TFA/물/트리이소프로필실란(95:2.5: 2.5)의 용액(10 mL / 100 mg 의 펩티딜-수지)을 펩티딜-수지에 첨가하고 혼합물을 가끔씩 저어주면서 실온에서 유지시켰다. 수지를 정제하고 분해 혼합물로 세척하고 결합된 여과액을 건조시키기 위해 증발시켰다. 수득한 잔류물을 10 mL 의 물에 용해시키고 수성층을 에테르(각각 20 mL)로 3 번 추출하고 최종적으로 수성층을 동결건조시켰다. 동결건조 후에 수득한 조 펩티드를 다음과 같이 조제용 HPLC 로 정제하였다 :
조 단쇄 펩티드의 조제용 HPLC 정제 :
조제용 HPLC 를 Shimadzu LC-8A 액체 크로마토그래피에서 실시하였다. DMF 또는 물에 용해시킨 조 펩티드의 용액을 semi-Prep 컬럼(Luna 10m; C18; 100 A0), 치수 250 X 50 mm 에 주입시키고, 용출액을 220 nm 로 PDA 검출기로 모니터하면서 15-50 mL 의 유량으로 둘 다 0.1 % TFA 에 완충시킨 물에 용해시킨 ACN 의 선형 구배로 용출시켰다. 0.1 % TFA 로 완충시킨 일반적인 구배(gradient)의 20 % 내지 70 % 의 물-ACN 혼합물을 1 분당 1 % 구배로 50 분 동안 사용하였다. 용출된 원하는 산물을 단일 10-20 mL 분획(fraction)으로 수집하고, 각각의 HPLC 분획물을 냉동건조시켜 순수한 단쇄 펩티드를 비결정성 백색의 분말로서 수득하였다.
정제된 단쇄 펩티드의 HPLC 분석 :
상기한 바와 같이 조제용 HPLC 로 정제한 후에, Shimadzu LC-10AD 분석 HPLC(analytical HPLC) 시스템에서 분석 RP-HPLC 로 각각의 펩티드를 분석하였다. 단쇄 펩티드의 분석 HPLC 분석을 위해서 0.1 % TFA 및 ACN 완충용액의 선형 구배로 Luna 5μ; C18; 100 Å 치수 250 X 4.6 mm 컬럼을 사용하였고, 크로마토그램의 수집(acquisition)을 PDA 검출기로 220 nm 에서 실시하였다.
질량 분석기에 의한 특성 :
플로 인젝션 분석(flow injection) 또는 LC/MS 방법으로 전기 스프레이 이온화 질량 분석법으로 각각의 펩티드를 특징지었다. 양이온 및 음이온 전기 스프레이 방법으로 삼단계 사중극자(Triple quadrupole) 질량 분석기[API-3000 (캐나다 MDS-SCIES로부터 입수)]를 모든 분석에서 사용하였다. 단위 분별(unit resolution)로 작동되고, 사중 극자의 질량 범위에서 모든 정밀 검사 데이터를 획득하였다. 모든 경우에 있어서, 실험적으로 측정된 분자량은 0.5 달톤의 측정된 단일 동위 원소 분자량(monoisotopic molecular weight)이었다. 질량 크로마토그램의 수량화를 Analyst 1.4.1 소프트웨어를 사용하여 실행하였다.
다른 일반적으로 공지된 기술 및 이의 적절한 변형된 방법과 마찬가지로 본원에 기재된 합성 방법을 사용하여, 다음의 신규한 단쇄 펩티드를 제조하였다[표 2(A-S)]. 표 2의 목록은 본 발명에 따라서 제조될 수 있는 다양한 그룹의 단쇄 펩티드를 나타내고, 이러한 단쇄 펩티드의 최소한의 명백한 변형물을 포함함을 예측할 수 있다. 그러나, 이러한 기재로 어떤 방법으로든 본 발명의 범위를 한정하는 것으로 이해해서는 안된다. 표 2(A-S)에서, 본 발명의 신규한 단쇄 펩티드를 이의 상응하는 Seq ID NO 로 리스트를 작성하였다.
[표 2]
A : 제조된 단쇄 펩티드 목록
Figure 112011085977158-pct00007

B: 제조된 단쇄 펩티드 목록
Figure 112011085977158-pct00008

C : 제조된 단쇄 펩티드 목록
Figure 112011085977158-pct00009

D : 제조된 단쇄 펩티드 목록
Figure 112011085977158-pct00010

E : 제조된 단쇄 펩티드 목록
Figure 112011085977158-pct00011

F : 제조된 단쇄 펩티드 목록
Figure 112011085977158-pct00012

G : 제조된 단쇄 펩티드 목록
Figure 112011085977158-pct00013
Figure 112011085977158-pct00014

2H : 제조된 단쇄 펩티드 목록
Figure 112011085977158-pct00015
Figure 112011085977158-pct00016

I : 제조된 단쇄 펩티드 목록
Figure 112011085977158-pct00017
Figure 112011085977158-pct00018

J : 제조된 단쇄 펩티드 목록
Figure 112011085977158-pct00019

Figure 112011085977158-pct00020

K : 제조된 단쇄 펩티드 목록
Figure 112011085977158-pct00021
Figure 112011085977158-pct00022

L : 제조된 단쇄 펩티드 목록
Figure 112011085977158-pct00023
Figure 112011085977158-pct00024

Figure 112011085977158-pct00025

M : 제조된 단쇄 펩티드 목록
Figure 112011085977158-pct00026
Figure 112011085977158-pct00027

N : 제조된 단쇄 펩티드 목록
Figure 112011085977158-pct00028

O: 제조된 단쇄 펩티드 목록
Figure 112011085977158-pct00029

P : 제조된 단쇄 펩티드 목록
Figure 112011085977158-pct00030
Figure 112011085977158-pct00031

Q : 제조된 단쇄 펩티드 목록
Figure 112011085977158-pct00032
Figure 112011085977158-pct00033

R : 제조된 단쇄 펩티드 목록
Figure 112011085977158-pct00034
Figure 112011085977158-pct00035

Figure 112011085977158-pct00036

S : 제조된 단쇄 펩티드 목록
Figure 112011085977158-pct00037
Figure 112011085977158-pct00038

신규한 단쇄 펩티드의 생체 외 및 생체 내에서의 연구 :
상기한 바와 같이 제조한 단쇄 펩티드를 다음과 같이 실험 하였다 ;
a) 생체 외에서 랫 PTH-1 R 작용물질 활성도(UMR-106 세포에서의 사이클릭 AMP 측정) ;
b) 인체 혈장, 인공 위액(simulated gastric fluid), 장액(intestinal fluid) 및 간 마이크로솜에서의 펩티드 안정성(탈체 : ex-vivo) ; 및
c) OVX 랫 모델에서 생체 내에서 실험한 항-골다공증 활성도.
a) 생체 외에서 랫 PTH -1 R 작용물질 활성도( UMR -106 세포에서의 사이클릭 AMP 측정) :
PTHR 은 GPCR 이고 PTHR 작용물질은 이에 결합하고 신호전달을 통해서 아데닐산 시클라아제(adenylate cyclase)를 활성화시키고 세포 내에서 cAMP 의 농도를 증가시킨다. 신규한 화합물의 효능적 활성을 모니터하기 위해서, 랫 PTHR, 특히 PTH-1R 이 내부에 발현된 UMR-106 랫의 골육종 세포(Source ATCC)를 다양한 농도의 실험 화합물로 처리하였고, 방출된 cAMP 의 양을 측정하였다.
UMR-106 세포를 10 % 소태아 혈청(FBS) 및 1X 펜스트렙(Penstrep)을 함유하는 DMEM 영양 배지(nutrition media)(Sigma)에 배양시켰다. 배양시킨 세포를 96-웰 조직 배양 플레이트에 10 % FBS 로 보충한 DMEM 배지에 웰 당 5 x 104 밀도의 세포로 도말하고 유효성 검정(efficacy assays)하기 전에 2 일 동안 성장시켰다. 검정하는 날에, 성장 배지를 석션(suction)으로 조심스럽게 제거하고 세포를 200 ㎕ 의 PBS 로 한번 세척하고, 90 ㎕ 반응 배지[플레인 DMEM 배지, 저농도의 글루코스, 0.1 % BSA(Sigma) 및 1 mM 3-이소부틸-1-메틸크산틴(Sigma)]에서 30 분 동안 37 ℃ 에서 배양하고 난 다음에 90 ㎕ 의 반응 배지에서 10 ㎕ 의 실험 화합물(농도 1, 10 및 100 nM)로 처리하고 30 분 동안 실온에서 배양하였다. 배지를 흡입시키고, 60 ㎕ 의 세포용출 완충용액(lysis buffer), 효소 공여체(ED) 기질 시약(enzyme donor substrate reagent)(40 ㎕) 및 cAMP-항체 시약을 첨가하고 플레이트를 1 시간 동안 실온에서 배양시켰다. 게다가, 효소 수용체(EA) 시약(enzyme acceptor reagent)을 첨가하고 2 시간 동안 실온에서 배양한 후에 Top Count L-Max 발광 측정 장치(Luminometer)(각 웰 마다 20초씩 판독)로 루미네센스(luminescence)를 판독하였다. cAMP 표준 곡선으로부터 방출된 cAMP 의 양을 측정하였다. 데이터는 대조군[매질(vehicle) : 물]의 백분률로 계산하고 평균 ±SD 로 표현하였다. 생체 외에서 PTH-1 수용체 효능적 활성을 갖는 대표적인 펩티드를 표 3 에 열거하였다. 선별된 실험 화합물의 EC50 를 측정하기 위해서 비-선형 회귀 곡선 피트(curve fit)[시그모이달 도스(Sigmoidal dose)]로 데이터를 분석하였다(Carter P. H.,등의., PNAS, 2007, 104(16), 6846-6851; Merritt B. S., J. Cellular Physiology, 2005, 152(3), 520-528; Reid I. R., Am. J. Physiol. Endocrinol. Metab., 253, 1987, E45-E50).
[표 3]
Figure 112011085977158-pct00039
Figure 112011085977158-pct00040

b) 인체 혈장, 인공 위액, 장액 및 간 마이크로솜에서의 펩티드 안정성( 탈체 )
0, 2, 4, 6, 12 및 24 시간 동안(37 ℃ ; 50 mM 트리에탄올아민-HCL 완충용액 ; pH 7.8) 인체 혈청(7.5 ㎕) 또는 인공 위액(pH 1.5 : 조성 HCL, NaCl 및 펩신) 또는 인공 장액(pH 7. 5) 또는 인체 간 마이크로솜에 상이한 단쇄 펩티드(최종 농도 2 μM)를 배양하였다. 24 시간 동안 관찰하여 시간-의존성 분해(time-dependent degradation)가 가능하도록 하여 1 시간 내에 대략 PTH(1-34)의 50 % 분해를 제공하는 인체 혈장/인공 위액/인공 장액/인체 간 마이크로솜의 농도를 예비 실험에서 선별하였다. TFA/H2O (15 mL, 10% (v/v))를 첨가하여 반응을 종료하였다. 그리고 난 다음 반응 산물을 Vydac C18 분석컬럼(4.6 x 250-mm)에 적용시키고 난 다음 대부분의 분해 단편을 온전한(intact) 단쇄 펩티드로 부터 분리시켰다. 컬럼을 1 mL/분의 유량으로 TFA/H20 로 평형을 유지시켰다. 70 % 아세토니트릴/H2O 에 용해시킨 0.1% (v/v) TFA를 사용하여, 용출시킨 용매의 아세토니트릴 농도를 10 분 동안 0% 내지 28% 로 증가시키고 30 분 동안 28% 내지 42% 로 증가시켰다. ESI-MS 분석 전에 UV 검출기를 사용하여 206 nm 에서 흡광도를 모니터하였고, 정점(peak)을 수집하였다. 실험 펩티드에 대한 곡선 아래의 영역을 측정하였고, 이들의 대사산물 및 분해 퍼센트를 24 시간 이상 각각의 시점에서 측정하였다. (생체 외) 인체 혈장, 인공 위액, 인공 장액 및 간 마이크로솜에서 선별된 펩티드의 안정성 연구 결과를 표 4 에 나타내었다.
[표 4]
Figure 112011085977158-pct00041
Figure 112011085977158-pct00042

c) 생체내 OVX 랫 모델에서 실험한 항-골다공증 활성도 :
생체 내에서 실험 화합물(단쇄 펩티드)의 항-골다공증 활성도를 연구하기 위해 난소가 절출된 랫(ovariectomiced rat : OVX 랫)을 사용하였다. 난소 호르몬 결핍증 때문에 OVX 랫은 골감소증이 생겼다. 난소를 적출하고 14일이 되면 골감소증이 감지되었고 100일 후에는 증상이 더 증가되었고 그 다음에는 안정화되었다(Wronski T. J. 등의., Calcif. Tissue Int., 43(3), 1988, 179-183).
OVX 동물에서 골 표지자( marker ) 및 조직형태계측에서 동화치료 효과를 증진시키는 자세한 연구 프로토콜 :
10 내지 11 주된 암컷 Wistar 랫(150-200 g)을 이용하였다. 조절된 온도(23℃ ± 3℃), 조명(12시간 : 12시간의 주-야간 사이클) 및 상대적인 습도(55 ± 10 %)로 공간에서 각기 환기된 케이지(cage)에서 동물을 키웠다. 동물은 랫 먹이 및 물에 자유롭게 접근할 수 있다. 이러한 연구를 실시하기 위한 동물의 사용에 대한 프로토콜은 재검토되었고 동물 실험 윤리 위원회(IAEC)에 의해 인가되었다.
연구를 시작하기 전에 식별을 위해서 피크르산으로 동물을 표지하고 2 일 동안 실험적인 실내 조건에 적응시켰다. 골다공증을 유도하기 위해서, 랫을 마취시키고 난소를 양쪽 다 적출하였다. 난소 절제술를 행하기 위해서, 동물의 옆구리 부위에 가까운 등쪽 옆 부위를 절개하였다. 그리고 난 다음에, 혈액 손실을 방지하기 위해서 혈관을 묶고 난소를 절개하였다. 절개 후에 결찰사(ligature)로 봉합하였다.
양쪽의 난소절제술 후에 동물을 4 주 동안 휴식을 취하게 하였다. 그리고 난 다음에 동물의 몸무게를 기초로 동물을 다른 그룹(n=9)으로 나누었다. 어떠한 치료도 하지 않는 대조군, 기준으로서의 PTH 및 실험 화합물(단쇄 펩티드)의 하나 또는 두 개의 그룹으로 이루어져 있다. 6주 동안 치료를 받았다. 치료 마지막 날에 소변을 모으기 위해서 단식시키고 실험 동물을 대사 케이지(metabolic cages)에 하룻밤 동안 두었다. 다음날 마지막으로 복용한지 24 시간이 지난 후에 혈액을 모으고 동물을 희생시켰다. 생화학적 파라미터 및 골 전환율(bone turnover) 파라미터에서의 변화(혈청에서 칼슘의 증가 및 인산염 농도, 산성 인산가수분해 효소 및 TRAP의 감소)를 소변과 혈청에서 평가하였다. 희생시킨 후에 온전한 대퇴골 및 경골을 적출하고 부착된 조직, 근육 및 힘줄을 제거하고 무게를 재고 포름 살린(formal saline)(10 % 포름알데히드 용액)에 모았다. 요추골(L5)를 절개하고 조심스럽게 깨끗하게 하고 포름 살린에 모았다. 대퇴골, 경골 및 요추골-5(L5)을 조직형태학적 평가를 위해 처리하였다(Zhang L., 등의l., Tohoku J Exp Med., 1998, 186(2), 131-41; Tanizawa T., 등의., Toxicol Lett., 1998,102, 399-403). 선별된 펩티드의 혈청에서의 칼슘 증가 및 인산염 농도(% 변화율 대 PTH)의 감소를 표 5 에 나타내었다.
[표 5]
Figure 112011085977158-pct00043

PTH(1-34)(도 1A) 및 Seq. ID No. 111(도 1B)의 (랫 PTH-1 R 검정에서의) 생체 외 DRC 연구 데이터(EC50)을 대표적인 도면으로써 도 1 에 나타내었다. OVX 암컷 Wister 랫에서 경구 투여로 상이한 복용량(0.1/0.2/0.3/0.5 mg/kg)으로 Seq. ID. No. 111 ((AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-2,6-F-Phe))로 6 주 치료한 후의 생체 내 DRC 연구 데이터를 대표적인 도면으로 도 3 에 나타내었다(도 3A : 혈청에서의 Ca2 + 농도의 증가율 % ; 도 3B : 혈청에서의 PO4 농도의 감소율 %). 도 4 는 Seq. ID No. 111 및 PTH(1-34)로 6 주 치료한 후의 OVX 랫에서의 생화학적 파라미터 및 대퇴골 무게의 변화를 도 4 에 나타내었다. Seq. ID No. 111 로 6 주 치료한 후에 OVX 랫에서 대퇴골, 경골 및 요추의 조직학적 단면도를 도 5, 6 및 7 에 나타내었다.
유용성 :
바람직한 실시형태에서, 본 발명은 UMR-106 세포에서 상이한 정도의 친화력(1-1000 nM 농도)을 갖는 PTH-1 수용체의 작용물질로서 작용하는 단쇄 펩티드를 제조하는 방법을 제공한다. PTH-1 수용체 효능적 활성을 실험 화합물에 의한 방출된 cAMP 의 양으로 평가하여 측정하였다(생체 외에서). OVX 마우스/랫 모델(생체 내)에서, 몇몇의 단쇄 펩티드는 골다공증의 치료 및 예방을 위한 골 성장 파라미터를 개선시켜 이상적인 치료상의 후보물질이 되었다.
본 발명의 신규한 단쇄 펩티드는 다양한 단백질 가수 분해 효소에 대비하여 증가된 안정성을 나타내었고, 이러한 증가된 안정성 및 단쇄 길이로 인하여 그 밖의 침습(invensive) 및 비-침습 경로의 투여와 함께 경구로 전달될 수 있다.
본 발명은 신규한 단쇄 펩티드를 공지된 적절한 부형제와 함께 적절한 약제학적으로 허용되는 조성물로 제형화시킬 수 있다.
일반적으로 이용되는 방법을 사용하여 약제학적 조성물을 제공한다. 바람직하게 조성물은 본 발명에 따른 유효량의 유효성분, 즉 화학식 1 의 단쇄 펩티드 단독 또는 조합물을 함유하는 단위 투여 형태(unit dosage form)이다. 본 분야에서 공지된 적절한 희석제, 안정제, 완충용액 등 중에서 선택한 적절한 부형제를 포함하는 적절한 부형제와 함께 화학식 1 의 화합물과 조합하여 공지된 제조방법으로 약제학적 조성물을 제조할 수 있다.
약제학적 조성물 및 이의 단위 투여 형태에서 유효성분, 즉 본 발명에 따른 화학식 1 의 단쇄 펩티드의 양은 특정한 응용 방법, 특정한 단쇄 펩티드의 효능 및 바람직한 농도에 따라 폭넓게 다양화 될 수 있거나 조절될 수 있다. 일반적으로 유효 성분의 양은 조성물의 무게에 따라 0.5 % 내지 90 % 범위이다.
이에 맞추어, 본 발명의 단쇄 펩티드를 다음을 포함하지만 이로 인하여 한정되지 않는 골다공증의 다양한 증상 및 장애를 치료하거나 예방하기 위해 동물, 바람직하게 인체에 투여할 수 있다 ;
초기 골다공증, 내분비성 골다공증(endocrine osteoporosis)(갑상선 기능 항진증, 부갑상선 기능 항진증, 쿠싱 증후군, 말단 비대증, 제1형 당뇨병, 부신피질 기능저하증), 유전적이고 선천적인 형태의 골다공증[(골형성 부전증, 호모시스틴뇨증, 멘케스 증후군, 릴리-데이 증후군(Riley-Day syndrome)], 영양 장애 및 위장 장애, 혈액 장애(haematological disorder)/악성 종양(다발성 골수종, 림프종, 백혈병, 혈우병, 탈라세미아), 부동화(immobilization), 만성 폐쇄성 폐질환 또는 류마티스성 질환(rheumatologic disorder)(류마티스 관절염, 척추염) 때문에 발생하는 골다공증, 골 손실을 유발하는 골수염, 뼈에서의 전염성 병변(infectious lesion).
고형 종양 및 혈액학적 악성 종양에 의한 고칼슘혈증, 특발성 고칼슘혈증(idiopathic hypercalcemia) 및 고칼슘혈증은 갑상선 기능 항진증 및 신장 기능 장애와 연관되어 있다. 수술 후의 골 감소증은 스테로이드 투여에 의해서 유도되고, 소장 및 대장의 장애 및 만성 간질환 및 신장 질환과 연관되어 있다. 외상성 손상(traumatic injury) 또는 비외상성 괴사(nontraumatic necrosis)와 연관된 골괴사증 또는 골 세포 사멸은 고셔병(Gaucher's disease), 겸상 적혈구 빈혈, 전신성 홍반성 루푸스 및 그밖의 증상과 연관되어 있다. 치주 골 손실(Periodontal bone loss), 골용해 전이(Osteolytic metastasis), 골절 치료 및 건선과 같은 과잉증식성 피부질환(hyperproliferative skin disorders).
사용된 약자
다음에 기재한 약자를 실시예 및 본원에 인용된 그 외에서 사용하였다 ;
Abu(CN) = 2-아미노-4-시아노부탄산,
Aib = α-아미노-이소부티르산,
Ala= 알라닌,
α-Me-APPA= 2-아미노-2-메틸-5-페닐발레르산,
α-Me-Bip(OMe)= α-메틸화 Bip(OMe),
αMe-Har = 알파-메틸-Har,
αMe-K = 알파-메틸-Lys,
αMe-M = 알파-메틸-Met,
αMe-Nle = 알파-메틸-노르류신,
αMe-Pro= 알파-메틸-프롤린,
α-Me-Phe = 알파-메틸-페닐알라닌,
α-Me-2F-Phe = 알파-메틸-2-플루오로페닐알라닌,
α-Me-2,6-F-Phe = 알파-메틸-2,6-디플루로페닐알라닌,
αMe-R = 알파-메틸-Arg,
αMe-Trp= 알파-메틸-트립토판,
αMe-Val= 알파-메틸-발린,
AC3C= 1-아미노 시클로프로판 카르복실산,
AC5C= 1-아미노-시클로펜탄카르복실산,
AC6C= 1-아미노-시클로헥산카르복실산,
ACN = 아세토니트릴,
APPA = 2-아미노-5-페닐발레르산,
Arg= 아르기닌,
Arg(NO2) = 아르기닌(니트로),
Asp= 아스파르테이트(Aspartate),
Asn= 아스파르긴,
Bn = 벤질,
Boc = tert-부톡시카르보닐,
Bip(OMe)= 2'-에틸-4'-메톡시-비페닐알라닌,
But= O-tert-부틸기,
cAMP= 아데노신 3',5'-사이클릭 모노포스페이트,
Cit = 시트룰린,
DCM = 디클로로메탄,
DMF = N,N-디메틸포름아미드,
DIPCDI= Di-이소프로필카르보디이미드,
DIPEA= 디이소프로필에틸아민,
Et = 에틸,
Et2O = 디에틸 에테르,
EtMet = 에티오닌,
Fmoc = 플루오레닐메톡시카르보닐,
2F-Phe = 2-플루오로페닐알라닌,
g = 그램(s),
Gly= 글리신,
Glu= 글루타메이트,
Gln= 글루타민,
Ile= 이소류신,
h = 시간(시),
His= 히스티딘,
Har = 호모아르기닌(Homoarginine),
HoCit = 호모시트룰린(Homocitrulline),
HoGlu = 호모글루탐산(Homoglutamic acid),
HoLeu = 호모류신(Homoleucine),
HOBt = 1-히드록시벤조트리아졸,
HOAt= 7-아자-히드록시벤조트리아졸(7-Aza-hydroxybenxotriazole),
HBTU = 2-(1H-벤조트리아졸-1-일)-1,1,3,3-테트라메틸 아미늄 헥사플루오로포스페이트,
HPLC = 고성능 액체 크로마토그래피,
K(Biotin) = 리신(비오틴),
K(NO2)= 리신(니트로),
L = 리터,
LC /MS = 액체 크로마토그래피 / 질량분석법,
Lys= 리신,
Me = 메틸,
Met= 메티오닌,
Min = 분(s),
mL = 밀리리터,
ml = 마이크로리터,
mg = 밀리그램(s),
mmol = 밀리몰(millimole)(s),
MS= 질량분석법,
Nva = 노르발린,
Nle = 노르류신,
(NMe)M = N-메틸-Met,
(NMe)Nle = N-메틸-Nle,
(NMe)K = N-메틸-Lys,
(NMe)R = N-메틸-Arg,
(NMe)Har = N-메틸-Har,
Orn = 오르니틴,
Orn(NO2)= 오르니틴(니트로),
po = 경구투여(per-oral administration),
Phe = 페닐알라닌,
PTH = 부갑상선 호르몬,
PTH-1r 작용물질 = 부갑상선 호르몬 수용체 작용물질,
PyBOP = 벤조트리아졸-1-일-옥시-트리스-피롤리디노-포스포늄 헥사플루오로포스페이트,
Pyr = 피로글루탐산(Pyroglutamic acid),
Pro = 프롤린,
sc = 피하경로 투여(Subcutaneous route of administration),
SPPS = 고체상 펩티드 합성(Solid Phase Peptide Synthesis),
SMet= 셀레노메티오닌,
TMS = 트리메틸실릴,
TIPS = 트리이소프로필실란,
TFA = 트리플루오로아세트산,
TBTU= 2-(1H-벤조트리아졸-1-일)-1,1,3,3-테트라메틸아미늄 테트라메틸아미니움 테트라플루오로보레이트,
Trt= 트리틸기(Trityl group),
Trp= 트립토판,
Val= 발린,
WR= 위스타 랫(Wistar Rats).
<110> CADILA HEALTHCARE LIMITED BAHEKAR, Rajesh H. JAIN, Mukul R. PATEL, Pankaj R. <120> Short-chain peptides as parathyroid hormone (PTH) receptor <130> MC-99-109 <150> 1095/MUM/2009 <151> 2009-04-24 <150> 225/MUM/2010 <151> 2010-01-28 <160> 955 <170> PatentIn version 3.5 <210> 1 <211> 34 <212> PRT <213> Homo sapiens <400> 1 Ser Val Ser Glu Ile Gln Leu Met His Asn Leu Gly Lys His Leu Asn 1 5 10 15 Ser Met Glu Arg Val Glu Trp Leu Arg Lys Lys Leu Gln Asp Val His 20 25 30 Asn Phe <210> 2 <211> 11 <212> PRT <213> Homo sapiens <400> 2 Ser Val Ser Glu Ile Gln Leu Met His Asn Leu 1 5 10 <210> 3 <211> 14 <212> PRT <213> Homo sapiens <400> 3 Ser Val Ser Glu Ile Gln Leu Met His Asn Leu Gly Lys His 1 5 10 <210> 4 <211> 15 <212> PRT <213> Homo sapiens <400> 4 Ser Val Ser Glu Ile Gln Leu Met His Asn Leu Gly Lys His Leu 1 5 10 15 <210> 5 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 5 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 6 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 6 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 7 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 7 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Pro Lys Phe 1 5 10 <210> 8 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 8 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Pro Lys Phe 1 5 10 <210> 9 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 9 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 10 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 10 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 11 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 11 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 12 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 12 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Pro Lys Phe 1 5 10 <210> 13 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 13 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Pro Lys Phe 1 5 10 <210> 14 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 14 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 15 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 15 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 16 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 16 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 17 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 17 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 18 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 18 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Pro Lys Phe 1 5 10 <210> 19 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 19 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Pro Lys Phe 1 5 10 <210> 20 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 20 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 21 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 21 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 22 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclohexane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 22 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 23 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclohexane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 23 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 24 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 24 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 25 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 25 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 26 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 26 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 27 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 27 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 28 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 28 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 29 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 29 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 30 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 30 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 31 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 31 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 32 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 32 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 33 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 33 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 34 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 34 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 35 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 35 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 36 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 36 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 37 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 37 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 38 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 38 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 39 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 39 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 40 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 40 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 41 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 41 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 42 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 42 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 43 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 43 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 44 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(114) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 44 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 45 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 45 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 46 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 46 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 47 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 47 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 48 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (10)..(10) <223> Modified residue at this position is 2-amino-4-cyanobutanoic acid (Abu (CN)), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 48 Ala Val Ala Glu Ile Gln Phe Met His Arg Arg Ala Lys Phe 1 5 10 <210> 49 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 49 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 50 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 50 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 51 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 51 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 52 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 52 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 53 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 53 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 54 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 54 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 55 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 55 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 56 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 56 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 57 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 57 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 58 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 58 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 59 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 59 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 60 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 60 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 61 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 61 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 62 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 62 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 63 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 63 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 64 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 64 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 65 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 65 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 66 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 66 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 67 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 67 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 68 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 68 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 69 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 69 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 70 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Lysine Biotin (K (Biotin)), which structurally mimics Lysine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 70 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 71 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 71 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 72 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 72 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 73 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 73 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 74 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 74 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 75 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 75 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 76 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 76 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 77 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 77 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 78 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 78 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 79 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 79 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 80 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 80 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 81 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 81 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 82 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 82 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 83 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 83 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 84 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 84 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 85 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 85 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 86 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (10)..(10) <223> Modified residue at this position is 2-amino-4-cyanobutanoic acid (Abu (CN)), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 86 Ala Val Ala Glu Ile Gln Phe Met His Arg Arg Ala Lys Phe 1 5 10 <210> 87 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclohexane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 87 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 88 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclohexane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 88 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 89 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclohexane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 89 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 90 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 90 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 91 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 91 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 92 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 92 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 93 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 93 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 94 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 94 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 95 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 95 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 96 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 96 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 97 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 97 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 98 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 98 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 99 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 99 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 100 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 100 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 101 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 101 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 102 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 102 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 103 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 103 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 104 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 104 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 105 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Lysine Biotin (K (Biotin)), which structurally mimics Lysine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 105 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 106 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 106 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 107 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 107 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 108 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 108 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 109 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 109 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 110 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 110 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 111 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 111 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 112 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 112 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 113 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 113 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 114 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 114 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 115 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 115 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 116 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 116 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 117 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 117 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 118 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 118 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 119 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 119 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Pro Lys Phe 1 5 10 <210> 120 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclohexane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 120 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Lys Phe 1 5 10 <210> 121 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 121 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 122 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-phenylalanine (alpha-Me-Phe-), which structurally mimics Phenylalanine <400> 122 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 123 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 123 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 124 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 124 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 125 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 125 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 126 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 126 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 127 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 127 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 128 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 128 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 129 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 129 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 130 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 130 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 131 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 131 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 132 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 132 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 133 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 133 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 134 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 134 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 135 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 135 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 136 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 136 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 137 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 137 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 138 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 138 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 139 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 139 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 140 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 140 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 141 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 141 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 142 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 142 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 143 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 143 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 144 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 144 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 145 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (10)..(10) <223> Modified residue at this position is 2-amino-4-cyanobutanoic acid (Abu (CN)), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 145 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 146 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 146 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 147 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 147 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 148 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 148 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 149 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 149 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 150 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 150 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 151 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 151 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 152 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 152 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 153 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -alpha-methyl proline (alpha-Me-Pro), which structurally mimics Proline <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 153 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 154 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 154 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 155 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 155 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 156 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 156 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 157 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 157 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 158 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 158 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 159 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 159 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 160 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 160 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 161 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 161 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 162 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 162 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 163 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 163 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 164 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 164 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 165 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 165 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 166 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 166 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 167 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 167 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 168 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 168 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 169 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 169 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 170 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 170 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 171 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 171 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 172 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 172 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 173 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 173 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 174 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 174 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 175 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 175 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 176 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 176 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 177 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 177 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 178 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 178 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 179 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 179 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 180 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 180 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 181 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 181 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 182 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 182 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 183 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 183 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 184 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 184 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 185 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 185 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 186 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 186 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 187 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 187 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 188 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 188 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 189 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 189 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 190 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 190 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 191 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 191 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 192 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 192 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 193 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 193 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 194 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 194 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 195 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 195 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 196 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 196 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 197 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 197 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 198 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 198 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 199 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 199 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 200 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 200 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 201 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 201 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 202 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 202 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 203 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 203 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 204 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 204 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 205 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 205 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 206 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 206 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 207 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 207 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 208 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 208 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 209 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 209 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 210 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 210 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 211 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 211 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 212 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 212 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 213 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 213 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 214 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 214 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 215 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 215 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 216 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 216 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 217 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 217 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 218 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 218 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 219 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 219 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 220 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 220 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 221 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 221 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 222 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 222 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 223 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 223 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 224 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 224 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 225 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 225 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 226 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 226 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 227 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 227 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 228 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 228 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 229 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 229 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 230 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 230 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 231 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 231 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 232 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 232 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 233 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 233 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 234 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 234 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 235 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 235 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 236 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 236 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 237 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 237 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 238 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 238 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 239 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 239 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 240 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 240 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 241 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 241 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 242 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 242 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 243 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 243 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 244 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 244 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 245 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 245 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 246 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 246 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 247 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 247 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 248 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 248 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 249 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 249 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 250 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 250 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 251 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 251 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 252 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 252 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 253 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 253 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 254 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 254 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 255 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 255 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 256 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 256 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 257 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 257 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 258 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 258 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 259 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 259 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 260 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 260 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 261 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 261 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 262 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 262 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 263 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 263 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 264 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 264 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 265 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 265 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 266 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 266 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 267 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 267 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 268 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 268 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 269 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 269 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 270 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 270 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 271 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 271 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 272 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 272 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 273 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 273 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 274 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopropane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 274 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 275 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 275 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 276 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 276 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 277 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 277 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 278 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 278 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 279 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 279 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 280 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 280 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 281 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 281 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 282 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 282 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 283 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 283 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 284 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 284 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 285 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 285 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 286 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 286 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 287 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 287 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 288 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 288 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 289 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 289 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 290 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 290 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 291 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 291 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 292 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 292 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 293 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 293 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 294 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 294 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 295 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 295 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 296 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 296 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 297 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 297 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 298 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 298 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 299 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 299 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 300 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 300 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 301 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 301 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 302 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 302 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 303 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 303 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 304 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 304 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 305 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 305 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 306 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 306 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 307 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 307 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 308 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 308 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 309 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 309 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 310 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 310 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 311 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 311 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 312 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 312 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 313 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 313 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 314 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 314 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 315 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 315 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 316 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 316 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 317 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 317 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 318 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 318 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 319 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 319 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 320 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 320 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 321 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 321 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 322 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 322 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 323 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 323 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 324 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 324 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 325 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 325 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 326 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 326 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 327 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 327 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 328 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 328 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 329 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 329 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 330 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 330 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 331 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 331 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 332 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 332 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 333 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 333 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 334 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 334 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 335 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 335 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 336 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 336 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 337 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 337 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 338 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 338 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 339 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 339 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 340 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 340 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 341 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 341 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 342 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 342 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 343 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 343 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 344 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Ornithine (Orn), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 344 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 345 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 345 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 346 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 346 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 347 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 347 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 348 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 348 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 349 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 349 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 350 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 350 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 351 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 351 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 352 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 352 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 353 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 353 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 354 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 354 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 355 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 355 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 356 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 356 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 357 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 357 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 358 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 358 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 359 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 359 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 360 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 360 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 361 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 361 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 362 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 362 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 363 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 363 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 364 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 364 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 365 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 365 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 366 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 366 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 367 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 367 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 368 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 368 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 369 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 369 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 370 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 370 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 371 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 371 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 372 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 372 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 373 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 373 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 374 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 374 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 375 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 375 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 376 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 376 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 377 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 377 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 378 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 378 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 379 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 379 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 380 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 380 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 381 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 381 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 382 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 382 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 383 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 383 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 384 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 384 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 385 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 385 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 386 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 386 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 387 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 387 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 388 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 388 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 389 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 389 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 390 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 390 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 391 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 391 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 392 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 392 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 393 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 393 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 394 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 394 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 395 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 395 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 396 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 396 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 397 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 397 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 398 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 398 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 399 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 399 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 400 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <400> 400 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 401 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 401 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 402 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 402 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 403 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 403 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 404 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2F-phenylalanine (alpha-Me-2F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 404 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 405 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 405 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 406 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 406 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 407 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 407 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 408 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is Amino cyclopentane carboxylic acid, which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle), which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit), which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) , which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-F-phenylalanine (alpha-Me-2,6-F-Phe), which structurally mimics Phenylalanine <400> 408 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 409 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 409 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 410 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 410 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 411 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 411 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 412 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 412 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 413 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 413 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 414 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 414 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 415 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 415 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 416 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 416 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 417 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 417 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 418 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 418 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 419 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 419 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 420 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 420 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 421 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 421 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 422 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 422 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 423 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 423 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 424 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 424 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 425 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 425 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 426 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 426 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 427 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 427 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 428 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 428 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 429 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 429 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 430 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 430 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 431 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 431 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 432 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 432 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 433 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 433 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 434 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 434 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 435 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 435 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 436 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 436 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 437 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 437 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 438 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 438 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 439 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 439 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 440 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 440 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe 1 5 10 <210> 441 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 441 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 442 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 442 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 443 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 443 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 444 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 444 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 445 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 445 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 446 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 446 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 447 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 447 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 448 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 448 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 449 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 449 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 450 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 450 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 451 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 451 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 452 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 452 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 453 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 453 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 454 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 454 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 455 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 455 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 456 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 456 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe 1 5 10 <210> 457 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 457 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 458 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 458 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 459 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 459 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 460 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 460 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 461 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 461 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 462 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 462 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 463 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 463 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 464 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 464 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 465 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 465 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 466 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 466 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 467 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 467 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 468 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 468 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 469 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 469 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 470 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 470 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 471 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 471 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 472 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 472 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe 1 5 10 <210> 473 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 473 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 474 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 474 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 475 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 475 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 476 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 476 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 477 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 477 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 478 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 478 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 479 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 479 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 480 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 480 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 481 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 481 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 482 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 482 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 483 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 483 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 484 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 484 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 485 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 485 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 486 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 486 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 487 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 487 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 488 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 488 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 489 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 489 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Ala Phe 1 5 10 <210> 490 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 490 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Ala Phe 1 5 10 <210> 491 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 491 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Ala Phe 1 5 10 <210> 492 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 492 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Ala Phe 1 5 10 <210> 493 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 493 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Ala Phe 1 5 10 <210> 494 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 494 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Ala Phe 1 5 10 <210> 495 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 495 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Ala Phe 1 5 10 <210> 496 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 496 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Ala Phe 1 5 10 <210> 497 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 497 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Ala Phe 1 5 10 <210> 498 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 498 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Ala Phe 1 5 10 <210> 499 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 499 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Ala Phe 1 5 10 <210> 500 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 500 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Ala Phe 1 5 10 <210> 501 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 501 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Ala Phe 1 5 10 <210> 502 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 502 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Ala Phe 1 5 10 <210> 503 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 503 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Ala Phe 1 5 10 <210> 504 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 504 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Ala Phe 1 5 10 <210> 505 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 505 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Phe Phe 1 5 10 <210> 506 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 506 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Phe Phe 1 5 10 <210> 507 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 507 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Phe Phe 1 5 10 <210> 508 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 508 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Phe Phe 1 5 10 <210> 509 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 509 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Phe Phe 1 5 10 <210> 510 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 510 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Phe Phe 1 5 10 <210> 511 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 511 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Phe Phe 1 5 10 <210> 512 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 512 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Phe Phe 1 5 10 <210> 513 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 513 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Phe Phe 1 5 10 <210> 514 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 514 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Phe Phe 1 5 10 <210> 515 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 515 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Phe Phe 1 5 10 <210> 516 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 516 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Phe Phe 1 5 10 <210> 517 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 517 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Phe Phe 1 5 10 <210> 518 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 518 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Phe Phe 1 5 10 <210> 519 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 519 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Phe Phe 1 5 10 <210> 520 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 520 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Phe Phe 1 5 10 <210> 521 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 521 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 522 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 522 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 523 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 523 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 524 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 524 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 525 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 525 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 526 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 526 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 527 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 527 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 528 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 528 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 529 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 529 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 530 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 530 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 531 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 531 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 532 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 532 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 533 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 533 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 534 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 534 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 535 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 535 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 536 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 536 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe 1 5 10 <210> 537 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 537 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 538 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 538 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 539 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 539 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 540 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 540 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 541 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 541 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 542 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 542 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 543 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 543 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 544 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 544 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 545 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 545 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 546 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 546 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 547 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 547 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 548 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 548 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 549 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 549 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 550 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 550 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 551 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 551 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 552 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 552 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 553 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 553 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Ala Phe 1 5 10 <210> 554 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 554 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Ala Phe 1 5 10 <210> 555 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 555 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Ala Phe 1 5 10 <210> 556 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 556 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Ala Phe 1 5 10 <210> 557 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 557 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Ala Phe 1 5 10 <210> 558 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 558 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Ala Phe 1 5 10 <210> 559 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 559 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Ala Phe 1 5 10 <210> 560 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 560 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Ala Phe 1 5 10 <210> 561 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 561 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Ala Phe 1 5 10 <210> 562 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 562 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Ala Phe 1 5 10 <210> 563 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 563 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Ala Phe 1 5 10 <210> 564 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 564 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Ala Phe 1 5 10 <210> 565 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 565 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Ala Phe 1 5 10 <210> 566 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 566 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Ala Phe 1 5 10 <210> 567 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 567 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Ala Phe 1 5 10 <210> 568 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 568 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Ala Phe 1 5 10 <210> 569 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 569 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Phe Phe 1 5 10 <210> 570 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 570 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Phe Phe 1 5 10 <210> 571 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 571 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Phe Phe 1 5 10 <210> 572 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 572 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Phe Phe 1 5 10 <210> 573 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 573 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Phe Phe 1 5 10 <210> 574 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 574 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Phe Phe 1 5 10 <210> 575 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 575 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Phe Phe 1 5 10 <210> 576 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 576 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Phe Phe 1 5 10 <210> 577 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 577 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Phe Phe 1 5 10 <210> 578 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 578 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Phe Phe 1 5 10 <210> 579 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 579 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Phe Phe 1 5 10 <210> 580 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 580 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Phe Phe 1 5 10 <210> 581 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 581 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Phe Phe 1 5 10 <210> 582 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 582 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Phe Phe 1 5 10 <210> 583 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 583 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Phe Phe 1 5 10 <210> 584 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 584 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Phe Phe 1 5 10 <210> 585 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 585 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 586 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 586 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 587 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 587 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 588 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 588 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 589 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 589 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 590 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 590 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 591 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 591 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 592 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 592 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 593 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 593 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 594 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 594 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 595 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 595 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 596 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 596 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 597 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 597 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 598 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 598 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 599 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 599 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 600 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is arginine (NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 600 Ala Val Ala Glu Ile Gln Phe Met His Gln Ala Ala Arg Phe 1 5 10 <210> 601 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 601 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 602 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 602 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 603 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 603 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 604 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> APPA: Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 604 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 605 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 605 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 606 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 606 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 607 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> APPA: Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 607 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 608 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 608 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 609 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 609 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 610 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> APPA: Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 610 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 611 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 611 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 612 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 612 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 613 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 613 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 614 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is homoarginine(NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 614 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 615 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is homoarginine(NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 615 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 616 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is homoarginine(NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 616 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 617 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is homoarginine(NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 617 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 618 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is homoarginine(NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 618 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 619 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is homoarginine(NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 619 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 620 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is homoarginine(NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 620 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 621 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is homoarginine(NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 621 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 622 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is homoarginine(NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 622 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 623 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is homoarginine(NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 623 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 624 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is homoarginine(NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 624 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 625 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is homoarginine(NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Lysine Biotin which structurally mimics with Lysine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 625 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 626 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is homoarginine(NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Lysine Biotin which structurally mimics with Lysine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 626 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 627 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Lysine Biotin which structurally mimics with Lysine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 627 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 628 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Lysine Biotin which structurally mimics with Lysine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 628 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 629 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is homoarginine(NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine K(CO(CH2)6-CH3) which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 629 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 630 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is homoarginine(NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine K(CO(CH2)6-CH3) which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 630 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 631 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 631 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 632 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine K(CO(CH2)6-CH3) which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 632 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 633 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is homoarginine(NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine K(CO(CH2)6-CH3) which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 633 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 634 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is homoarginine(NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine K(CO(CH2)6-CH3) which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 634 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 635 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine K(CO(CH2)6-CH3) which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 635 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 636 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine K(CO(CH2)6-CH3) which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 636 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 637 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine K(CO(CH2)6-CH3) which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 637 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 638 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is homoarginine(NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position N-methyl Lysine which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 638 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 639 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is homoarginine(NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position N-methyl Lysine which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 639 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 640 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine K(CO(CH2)6-CH3) which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 640 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 641 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is N-methyl Norleucine which structurally mimics with methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine K(CO(CH2)6-CH3) which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 641 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 642 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is N-methyl methionine which structurally mimics with methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is homoarginine(NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position N-methyl Lysine which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 642 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 643 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is N-methyl Norleucine which structurally mimics with methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is homoarginine(NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position N-methyl Lysine which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 643 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 644 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is N-methyl methionine which structurally mimics with methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is homoarginine(NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position N-methyl Lysine which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 644 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 645 <211> 15 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is N-methyl Norleucine which structurally mimics with methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is homoarginine(NO2) which structurally mimics with Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position N-methyl Lysine which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-Amino-5-phenylpentanoic acid which structurally mimics with phenylalanine. <400> 645 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 646 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 646 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 647 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 647 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 648 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 648 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 649 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 649 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 650 <211> 14 <212> PRT <213> Artificial <220> <223> This short chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position mimics -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is -Homo arginine which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is -alpha methyl phenylalanine which structurally mimics Phenylalanine. <400> 650 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 651 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-propane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 651 Ala Val Ala Glu Ile Gln Leu Leu His Gln Arg Ala Lys Phe 1 5 10 <210> 652 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is amino cyclo-propane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 652 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 653 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is amino cyclo-propane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 653 Ala Val Ala Glu Ile Gln Leu Leu His Gln Arg Ala Lys Phe 1 5 10 <210> 654 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-propane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is amino cyclo-propane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 654 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 655 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-propane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is amino cyclo-propane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 655 Ala Val Ala Glu Ile Gln Leu Leu His Gln Arg Ala Lys Phe 1 5 10 <210> 656 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is amino cyclo-propane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 656 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 657 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is amino cyclo-propane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 657 Ala Val Ala Glu Ile Gln Leu Leu His Gln Arg Ala Lys Phe 1 5 10 <210> 658 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (NO2) which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 658 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 659 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (NO2) which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 659 Ala Val Ala Glu Ile Gln Leu Leu His Gln Arg Ala Lys Phe 1 5 10 <210> 660 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (NO2) which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Lysine Biotin which structurally mimics with Lysine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 660 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 661 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (NO2) which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Lysine Biotin which structurally mimics with Lysine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 661 Ala Val Ala Glu Ile Gln Leu Leu His Gln Arg Ala Lys Phe 1 5 10 <210> 662 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Lysine Biotin which structurally mimics with Lysine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 662 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 663 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Lysine Biotin which structurally mimics with Lysine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 663 Ala Val Ala Glu Ile Gln Leu Leu His Gln Arg Ala Lys Phe 1 5 10 <210> 664 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine(NO2) which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine K(CO(CH2)6-CH3) which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 664 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 665 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine(NO2) which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine K(CO(CH2)6-CH3) which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 665 Ala Val Ala Glu Ile Gln Leu Leu His Gln Arg Ala Lys Phe 1 5 10 <210> 666 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine(NO2) which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine K(CO(CH2)6-CH3) which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 666 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 667 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine K(CO(CH2)6-CH3) which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 667 Ala Val Ala Glu Ile Gln Leu Leu His Gln Arg Ala Lys Phe 1 5 10 <210> 668 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine(NO2) which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine K(CO(CH2)6-CH3) which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 668 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 669 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine(NO2) which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine K(CO(CH2)6-CH3) which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 669 Ala Val Ala Glu Ile Gln Leu Leu His Gln Arg Ala Lys Phe 1 5 10 <210> 670 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine K(CO(CH2)6-CH3) which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 670 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 671 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is -alpha amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine K(CO(CH2)6-CH3) which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 671 Ala Val Ala Glu Ile Gln Leu Leu His Gln Arg Ala Lys Phe 1 5 10 <210> 672 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is amino cyclo-propane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine K(CO(CH2)6-CH3) which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 672 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 673 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is amino cyclo-propane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine K(CO(CH2)6-CH3) which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 673 Ala Val Ala Glu Ile Gln Leu Leu His Gln Arg Ala Lys Phe 1 5 10 <210> 674 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is amino cyclo-propane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine(NO2) which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position N-methyl Lysine which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 674 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 675 <211> 14 <212> PRT <213> Artificial <220> <223> This sequence was synthetically synthesisized and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is amino cyclo-pentane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is amino cyclo-propane carboxylic acid which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is -Norleucine which structurally mimics Methionine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine(NO2) which structurally mimics with Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position N-methyl Lysine which structurally mimics with Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine which structurally mimics with Phenylalanine. <400> 675 Ala Val Ala Glu Ile Gln Leu Leu His Gln Arg Ala Lys Phe 1 5 10 <210> 676 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is N-methyl methionine ((NMe)M) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine (K(-CO-(CH2)8-CH3)) which structurally mimics Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine. <400> 676 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 677 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is N-methyl Norleucine ((NMe)Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine (K(-CO-(CH2)8-CH3)) which structurally mimics Lysine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <400> 677 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 678 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is N-methyl methionine ((NMe)M) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Alkylated lysine (K(-CO-(CH2)8-CH3)) which structurally mimics Lysine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <400> 678 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 679 <211> 14 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is N-methyl Norleucine ((NMe)Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Alkylated lysine (K(-CO-(CH2)8-CH3)) which structurally mimics Lysine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <400> 679 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe 1 5 10 <210> 680 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 680 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 681 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 681 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 682 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(13) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 682 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 683 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 683 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 684 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 684 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 685 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 685 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 686 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is N-methyl methionine ((NMe)M) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine (K(-CO-(CH2)8-CH3)) which structurally mimics Lysine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine. <400> 686 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 687 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is N-methyl Norleucine ((NMe)Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alkylated lysine (K(-CO-(CH2)8-CH3)) which structurally mimics Lysine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <400> 687 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 688 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 688 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 689 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics alanine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 689 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 690 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 690 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 691 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 691 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 692 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(13) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 692 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 693 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine ( -Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 693 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 694 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 694 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 695 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine ( -Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 695 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 696 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino isobutyric acid (Aib), which structurally mimics alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine ( -Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 696 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 697 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 697 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 698 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine ( -Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 698 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 699 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha -Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 699 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 700 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine. <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha -Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 700 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 701 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 701 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 702 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 702 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 703 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 703 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 704 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 704 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 705 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 705 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 706 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 706 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 707 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 707 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 708 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 708 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 709 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 709 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 710 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 710 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 711 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 711 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 712 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 712 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 713 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 713 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 714 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 714 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 715 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 715 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 716 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 716 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 717 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 717 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 718 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 718 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 719 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 719 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 720 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 720 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 721 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 721 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 722 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 722 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 723 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 723 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 724 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 724 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 725 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 725 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 726 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 726 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 727 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 727 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 728 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 728 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 729 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Arginine(Nitro) (Arg(NO2)) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 729 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 730 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 730 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 731 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 731 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 732 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 732 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 733 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 733 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 734 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 734 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 735 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 735 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 736 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 736 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 737 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 737 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 738 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 738 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 739 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 739 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 740 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 740 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 741 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 741 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 742 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 742 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 743 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 743 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 744 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 744 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 745 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 745 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 746 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 746 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 747 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 747 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 748 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 748 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 749 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 749 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 750 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 750 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 751 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 751 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 752 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 752 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 753 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 753 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 754 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 754 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 755 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 755 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 756 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 756 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 757 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 757 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 758 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 758 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 759 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 759 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 760 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 760 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 761 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 761 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 762 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 762 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 763 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 763 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 764 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 764 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 765 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 765 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 766 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 766 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 767 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 767 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 768 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 768 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 769 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 769 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 770 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 770 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 771 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 771 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 772 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 772 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 773 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 773 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 774 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 774 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 775 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 775 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 776 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 776 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 777 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 777 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 778 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 778 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 779 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 779 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 780 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 780 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 781 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 781 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 782 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 782 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 783 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 783 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 784 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 784 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 785 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 785 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 786 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 786 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 787 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 787 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 788 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 788 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 789 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 789 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 790 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 790 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 791 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 791 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 792 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 792 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 793 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 793 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 794 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 794 Ala Val Ala Glu Ile Gln Leu Met His Gln Phe Ala Arg Phe Phe 1 5 10 15 <210> 795 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 795 Ala Val Ala Glu Ile Gln Leu Met His Gln Phe Ala Arg Phe Phe 1 5 10 15 <210> 796 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 796 Ala Val Ala Glu Ile Gln Leu Met His Gln Phe Ala Arg Phe Phe 1 5 10 15 <210> 797 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine. <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 797 Ala Val Ala Glu Ile Gln Leu Met His Gln Phe Ala Arg Phe Phe 1 5 10 15 <210> 798 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 798 Ala Val Ala Glu Ile Gln Leu Met His Gln Phe Ala Ala Phe Phe 1 5 10 15 <210> 799 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 799 Ala Val Ala Glu Ile Gln Leu Met His Gln Phe Ala Ala Phe Phe 1 5 10 15 <210> 800 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 800 Ala Val Ala Glu Ile Gln Leu Met His Gln Phe Ala Phe Phe Phe 1 5 10 15 <210> 801 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 801 Ala Val Ala Glu Ile Gln Leu Met His Gln Phe Ala Phe Phe Phe 1 5 10 15 <210> 802 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 802 Ala Val Ala Glu Ile Gln Leu Met His Gln Phe Ala Arg Phe Phe 1 5 10 15 <210> 803 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 803 Ala Val Ala Glu Ile Gln Leu Met His Gln Phe Ala Arg Phe Phe 1 5 10 15 <210> 804 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 804 Ala Val Ala Glu Ile Gln Leu Met His Gln Phe Ala Arg Phe Phe 1 5 10 15 <210> 805 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 805 Ala Val Ala Glu Ile Gln Leu Met His Gln Phe Ala Arg Phe Phe 1 5 10 15 <210> 806 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 806 Ala Val Ala Glu Ile Gln Leu Met His Gln Phe Ala Ala Phe Phe 1 5 10 15 <210> 807 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 807 Ala Val Ala Glu Ile Gln Leu Met His Gln Phe Ala Ala Phe Phe 1 5 10 15 <210> 808 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 808 Ala Val Ala Glu Ile Gln Leu Met His Gln Phe Ala Phe Phe Phe 1 5 10 15 <210> 809 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 809 Ala Val Ala Glu Ile Gln Leu Met His Gln Phe Ala Phe Phe Phe 1 5 10 15 <210> 810 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 810 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 811 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 811 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 812 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 812 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 813 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 813 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 814 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 814 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 815 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 815 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 816 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 816 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 817 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 817 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 818 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 818 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 819 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 819 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 820 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 820 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 821 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 821 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 822 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 822 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 823 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 823 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 824 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 824 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 825 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 825 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 826 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 826 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 827 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 827 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 828 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 828 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 829 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 829 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 830 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 830 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 831 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 831 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 832 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 832 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 833 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 833 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 834 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 834 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 835 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 835 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 836 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 836 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 837 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 837 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 838 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 838 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 839 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 839 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 840 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 840 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 841 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Orn which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 841 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 842 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 842 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 843 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 843 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 844 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 844 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 845 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 845 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 846 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 846 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 847 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 847 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 848 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 848 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 849 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 849 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 850 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 850 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 851 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 851 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 852 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 852 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 853 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 853 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 854 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 854 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 855 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 855 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 856 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 856 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 857 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 857 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 858 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 858 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 859 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 859 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 860 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 860 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 861 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 861 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 862 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 862 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 863 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 863 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 864 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 864 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 865 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 865 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 866 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 866 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 867 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 867 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 868 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 868 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 869 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 869 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 870 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 870 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 871 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 871 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Ala Phe Phe 1 5 10 15 <210> 872 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 872 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 873 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is HomoCitrulline (HoCit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 873 Ala Val Ala Glu Ile Gln Phe Met His Gln Arg Ala Phe Phe Phe 1 5 10 15 <210> 874 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 874 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe Phe 1 5 10 15 <210> 875 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 875 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe Phe 1 5 10 15 <210> 876 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 876 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe Phe 1 5 10 15 <210> 877 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 877 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe Phe 1 5 10 15 <210> 878 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 878 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Ala Phe Phe 1 5 10 15 <210> 879 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 879 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Ala Phe Phe 1 5 10 15 <210> 880 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 880 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Phe Phe Phe 1 5 10 15 <210> 881 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 881 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Phe Phe Phe 1 5 10 15 <210> 882 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 882 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe Phe 1 5 10 15 <210> 883 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 883 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe Phe 1 5 10 15 <210> 884 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 884 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe Phe 1 5 10 15 <210> 885 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Citrulline (Cit) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 885 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Arg Phe Phe 1 5 10 15 <210> 886 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 886 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Ala Phe Phe 1 5 10 15 <210> 887 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 887 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Ala Phe Phe 1 5 10 15 <210> 888 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 888 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Phe Phe Phe 1 5 10 15 <210> 889 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (7)..(7) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 889 Ala Val Ala Glu Ile Gln Phe Met His Gln Phe Ala Phe Phe Phe 1 5 10 15 <210> 890 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-Me-Bip(OMe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 890 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Ala Phe 1 5 10 15 <210> 891 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-Me-Bip(OMe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 891 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Ala Phe 1 5 10 15 <210> 892 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-Me-Bip(OMe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 892 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 893 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-Me-Bip(OMe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 893 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 894 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-Me-V which structurally mimics Valine <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-Me-Bip(OMe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 894 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 895 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-Me-V which structurally mimics Valine <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-Me-Bip(OMe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 895 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 896 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is NMe-V which structurally mimics Valine <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-Me-Bip(OMe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 896 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 897 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is NMe-V which structurally mimics Valine <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-Me-Bip(OMe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 897 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Lys Phe Phe 1 5 10 15 <210> 898 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-Me-Bip(OMe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 898 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Ala Phe 1 5 10 15 <210> 899 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 899 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Ala Phe 1 5 10 15 <210> 900 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 900 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 901 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 901 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 902 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-Me-Bip(OMe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 902 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Ala Phe 1 5 10 15 <210> 903 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-Me-Bip(OMe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 903 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Ala Phe 1 5 10 15 <210> 904 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 904 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 905 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 905 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 906 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-Me-V which structurally mimics Valine <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 906 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 907 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-Me-V which structurally mimics Valine <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 907 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 908 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is NMe-V which structurally mimics Valine <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 908 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 909 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is NMe-V which structurally mimics Valine <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is Norleucine (Nle) which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 909 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 910 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is alpha-Me-V which structurally mimics Valine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-Me-Bip(OMe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 910 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Ala Phe 1 5 10 15 <210> 911 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-Me-Bip(OMe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 911 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Ala Phe 1 5 10 15 <210> 912 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 912 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 913 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 913 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 914 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-Me-M which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-Me-Bip(OMe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 914 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Ala Phe 1 5 10 15 <210> 915 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-Me-Bip(OMe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 915 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Ala Phe 1 5 10 15 <210> 916 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-Me-V which structurally mimics Valine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-Me-Bip(OMe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 916 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Ala Phe 1 5 10 15 <210> 917 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-Me-Bip(OMe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 917 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Ala Phe 1 5 10 15 <210> 918 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-Me-Bip(OMe) which structurally mimics Phenyl alanine. <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 918 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Ala Phe 1 5 10 15 <210> 919 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 919 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Ala Phe 1 5 10 15 <210> 920 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-Me-M which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 920 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 921 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 921 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 922 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-Me-M which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 922 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 923 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 923 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 924 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-Me-M which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 924 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 925 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 925 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 926 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-Me-V which structurally mimics Valine <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 926 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 927 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-Me-V which structurally mimics Valine <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 927 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 928 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is NMe-V which structurally mimics Valine <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-Me-M which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 928 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 929 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is NMe-V which structurally mimics Valine <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2'-Ethyl-4'-methoxy-biphenylalanine (Bip(OMe)) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 929 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 930 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is alpha-Me-M which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 930 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 931 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 931 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 932 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-Me-M which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 932 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 933 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 933 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 934 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-Me-M which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 934 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 935 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 935 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 936 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-Me-M which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 936 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 937 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 937 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 938 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-Me-V which structurally mimics Valine <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-Me-M which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 938 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 939 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-Me-V which structurally mimics Valine <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 939 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 940 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is NMe-V which structurally mimics Valine <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-Me-M which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 940 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 941 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is NMe-V which structurally mimics Valine <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-methyl-2,6-diflurophenylalanine (alpha-Me-2,6F-Phe) which structurally mimics Phenyl alanine <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 941 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Phe Phe 1 5 10 15 <210> 942 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is alpha-Me-M which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-Me-Trp mimics Trp <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 942 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Trp Phe 1 5 10 15 <210> 943 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-Me-Trp mimics Trp <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 943 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Trp Phe 1 5 10 15 <210> 944 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is alpha-Me-M which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-Me-Trp mimics Trp <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 944 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Trp Phe 1 5 10 15 <210> 945 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is alpha-Me-M which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-Me-Trp mimics Trp <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 945 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Trp Phe 1 5 10 15 <210> 946 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is alpha-Me-M which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-Me-Trp mimics Trp <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 946 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Trp Phe 1 5 10 15 <210> 947 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-Me-Trp mimics Trp <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 947 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Trp Phe 1 5 10 15 <210> 948 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is alpha-Me-M which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-Me-Trp mimics Trp <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 948 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Trp Phe 1 5 10 15 <210> 949 <211> 15 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (3)..(3) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (8)..(8) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (11)..(11) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (13)..(13) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is alpha-Me-Trp mimics Trp <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is 2-amino-5-phenylpentanoic acid (APPA) which structurally mimics Phenyl alanine <400> 949 Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Trp Phe 1 5 10 15 <210> 950 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-Me-M which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-Me-Trp mimics Trp <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 950 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Trp Phe 1 5 10 15 <210> 951 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino cyclopropane carboxylic acid (AC3C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-Me-Trp mimics Trp <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 951 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Trp Phe 1 5 10 15 <210> 952 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-Me-M which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-Me-Trp mimics Trp <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 952 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Trp Phe 1 5 10 15 <210> 953 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-Me-Trp mimics Trp <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 953 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Trp Phe 1 5 10 15 <210> 954 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-Me-V which structurally mimics Valine <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-Me-M which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-Me-Trp mimics Trp <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 954 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Trp Phe 1 5 10 15 <210> 955 <211> 16 <212> PRT <213> Artificial <220> <223> This short-chain peptide was synthetically generated and prepared <220> <221> MISC_FEATURE <222> (1)..(1) <223> Modified residue at this position is alpha-Me-V which structurally mimics Valine <220> <221> MISC_FEATURE <222> (2)..(2) <223> Modified residue at this position is 1-amino-cyclopentanecarboxylic acid (AC5C) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (4)..(4) <223> Modified residue at this position is alpha-amino-isobutyric acid (Aib) which structurally mimics Alanine <220> <221> MISC_FEATURE <222> (9)..(9) <223> Modified residue at this position is alpha-MeNle which structurally mimics Methionine <220> <221> MISC_FEATURE <222> (12)..(12) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (14)..(14) <223> Modified residue at this position is Homoarginine (Har) which structurally mimics Arginine <220> <221> MISC_FEATURE <222> (15)..(15) <223> Modified residue at this position is alpha-Me-Trp mimics Trp <220> <221> MISC_FEATURE <222> (16)..(16) <223> Modified residue at this position is alpha-Me-APPA which structurally mimics Phenyl alanine <400> 955 Val Ala Val Ala Glu Ile Gln Leu Met His Gln Arg Ala Arg Trp Phe 1 5 10 15

Claims (23)

  1. 다음의 화학식 1 의 서열을 갖는 분리된 단쇄 펩티드의 호변이성체(tautomer) 및 용매 화합물을 포함하는, 다음의 화학식 1 의 서열을 갖는 분리된 단쇄 펩티드 :

    화학식 1
    A-Z1-Z2-Z3-Z4-Z5-Z6-Z7-Z8-Z9-Z10-Z11-Z12-Z13-Z14-Z15-B

    (여기에서,
    A는 -NH-R1 또는 R3-CO-NH-기를 나타내고,
    여기에서,
    R1 은 수소, 비오틴, 선형 또는 가지형 (C1-18) 알킬 사슬, 또는 피로글루탐산(Pyr), Pro(P), 알파-메틸-프롤린(αMe-P), Val(V), N-메틸-발린(NMe-V), 알파-메틸-발린(αMe-V), Lys(비오틴), Lys(알킬), Lys(아세틸)과 같은 아미노산을 나타내고 ;
    R3 은 선형 또는 가지형(C1-18) 알킬 사슬, (C1-6)알콕시, (C3-C6)시클로알킬, 아릴, 헤테로아릴 또는 아릴알킬기 중에서 선택한 것이고 :

    B는 -COOR2, -CONHR2 또는 CH2OR2 을 나타내고,
    여기에서,
    R2 는 H 또는 Val(V), 알파-메틸-발린(αMe-V), Lys(비오틴), Lys(알킬) 및 Lys(아세틸) 중에서 선택한 아미노산을 나타내고 :

    각각의 Z1, Z3 및 Z12 는 동일하거나 상이할 수 있으며, 독립적으로 Ser(S), 알파-메틸-세린(αMe-S), Val(V), 알파-메틸-발린(αMe-V), Pro(P), 알파-메틸-프롤린(αMe-P), Gly(G), Ala(A), α-아미노-이소부티르산(Aib), 1-아미노 시클로프로판 카르복실산(AC3C), 1-아미노-시클로펜탄카르복실산(AC5C), 1-아미노-시클로헥산카르복실산(AC6C) 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않은 아미노산을 나타내고 :

    Z2는 Val(V) 또는 αMe-Val(αMe-V)을 나타내고 :

    각각의 Z4, Z6 및 Z10은 동일하거나 상이할 수 있으며, 독립적으로 Glu(E), 호모글루탐산(Homoglutamic acid : HoGlu), 2-아미노-4-시아노부탄산(Abu(CN)), Asp(D), Asn(N), Gln(Q), Aib 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내고,

    각각의 Z5, Z7 및 Z9 은 동일하거나 상이할 수 있으며, 독립적으로 Leu(L), Ile(I), Nle(노르류신), Nva(노르발린), HoLeu(호모류신: Homoleucine), Abu(CN), His(H), Phe(F), 알파-메틸-페닐알라닌(-α-Me-Phe-), 알파-메틸-2-플루오로페닐알라닌(-α-Me-2F-Phe-) 또는 알파-메틸-2,6-디플루로페닐알라닌(-α-Me-2,6-F-Phe-) 또는 2-플루오로페닐알라닌(-2F-Phe-)기 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내고 ;

    Z8 은 Met, N-메틸-Met((NMe)M), 알파-메틸-Met(αMe-M), 알파-메틸-발린(αMe-V), Leu, Nle, N-메틸-Nle((NMe)Nle), 알파-메틸-노르류신(αMe-Nle), Nva, HoLeu, 에티오닌(EtMet), 셀레노메티오닌(SMet), Val 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내고 ;

    Z11 및 Z13 은 동일하거나 상이할 수 있으며, 독립적으로 Aib, Pro(P), αMe-Pro, 리신(K), 리신-비오틴(K(비오틴)), 리신(니트로)[K(NO2)], 아르기닌(R), 아르기닌(니트로)[(Arg(NO2)], 호모아르기닌(Homoarginine : Har), 오르니틴(Orn), 오르니틴(니트로)[Orn(NO2)], 시트룰린(Cit), 호모시트룰린(Homocitrulline : HoCit), Phe(F), 알파-메틸-페닐알라닌(-α-Me-Phe-), 알파-메틸-2-플루오로페닐알라닌(-α-Me-2F-Phe-) 또는 알파-메틸-2,6-디플루로페닐알라닌(-α-Me-2,6-F-Phe-) 또는 2-플루오로페닐알라닌(-2F-Phe-) 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내고 ;

    Z14 는 2'-에틸-4'-메톡시-비페닐알라닌(Bip(OMe)), α-메틸화 Bip(OMe)[αMe-Bip(OMe)], αMe-Trp, 알파-메틸-페닐알라닌(-α-Me-Phe-), 알파-메틸-2-플루오로페닐알라닌(-α-Me-2F-Phe-), 알파-메틸-2,6-디플루로페닐알라닌(-α-Me-2,6-F-Phe-) 또는 2-플루오로페닐알라닌(-2F-Phe-)기 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내며 ;

    Z15 는 존재하거나 존재하지 않으며, 존재할 때 Z15 는 2-아미노-5-페닐발레르산(APPA) 또는 2-아미노-2-메틸-5-페닐발레르산(α-Me-APPA) 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타낸다).
  2. 제 1 항에 있어서, A는 -NH-R1 또는 R3-CO-NH-기를 나타내고, R1은 수소, 비오틴 또는 피로글루탐산(Pyr), Pro(P) 및 Val(V) 중에서 선택한 아미노산을 나타냄을 특징으로 하는 화합물.
  3. 제 1 항에 있어서, R3은 추가적으로 치환된 선형 또는 가지형(C1-18) 알킬 사슬 중에서 선택한 것임을 특징으로 하는 화합물.
  4. 제 1 항에 있어서, B는 -COOR2, -CONHR2를 나타내며, R2는 H 또는 Val(V), 알파-메틸-발린(αMe-V) 또는 Lys(비오틴) 중에서 선택한 아미노산을 나타냄을 특징으로 하는 화합물.
  5. 제 1 항에 있어서, 각각의 Z1, Z3 및 Z12 은 동일하거나 상이할 수 있으며, 독립적으로 Ala(A), α-아미노-이소부티르산(Aib), 1-아미노 시클로프로판 카르복실산(AC3C), 1-아미노-시클로펜탄카르복실산(AC5C), 1-아미노-시클로헥산카르복실산(AC6C) 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타냄을 특징으로 하는 화합물.
  6. 제 1 항에 있어서, Z2 는 Val(V)를 나타냄을 특징으로 하는 화합물.
  7. 제 1 항에 있어서, 각각의 Z4, Z6 및 Z10 은 동일하거나 상이할 수 있으며, 독립적으로 Glu(E), Gln(Q) 또는 Aib 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타냄을 특징으로 하는 화합물.
  8. 제 1 항에 있어서, 각각의 Z5, Z7 및 Z9 은 동일하거나 상이할 수 있으며, 독립적으로 Leu(L), Ile(I), Nle, HoLeu(호모류신), His(H), 알파-메틸-2-플루오로페닐알라닌(-α-Me-2F-Phe-) 또는 알파-메틸-2,6-디플루로페닐알라닌(-α-Me-2,6-F-Phe-) 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타냄을 특징으로 하는 화합물.
  9. 제 1 항에 있어서, Z8 은 Met, 알파-메틸-Met(αMe-M), Nle, N-메틸-Nle((NMe)Nle) 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타냄을 특징으로 하는 화합물.
  10. 제 1 항에 있어서, 각각의 Z11 및 Z13 은 동일하거나 상이할 수 있으며, 독립적으로 Aib, αMe-Pro, 리신(K), 리신-비오틴(K(비오틴)), K(NO2), 아르기닌(R), Arg(NO2), 호모아르기닌(Har), 오르니틴(Orn), Orn(NO2), 시트룰린(Cit), 호모시트룰린(HoCit), 알파-메틸-2-플루오로페닐알라닌(-α-Me-2F-Phe-) 또는 알파-메틸-2,6-디플루로페닐알라닌(-α-Me-2,6-F-Phe-) 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타냄을 특징으로 하는 화합물.
  11. 제 1 항에 있어서, Z14는 2'-에틸-4'-메톡시-비페닐알라닌(Bip(OMe)), α-메틸화 Bip(OMe)[αMe-Bip(OMe)], 알파-메틸-2-플루오로페닐알라닌(-α-Me-2F-Phe-) 또는 알파-메틸-2,6-디플루로페닐알라닌(-α-Me-2,6-F-Phe-) 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타냄을 특징으로 하는 화합물.
  12. 제 1 항에 있어서, Z15는 2-아미노-5-페닐발레르산(APPA) 또는 2-아미노-2-메틸-5-페닐발레르산(α-Me-APPA) 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타냄을 특징으로 하는 화합물.
  13. 제 1 항에 있어서, 아릴기는 페닐, 나프틸, 인다닐, 플루오레닐 또는 비페닐기 중에서 선택한 것임을 특징으로 하는 화합물.
  14. 제 1 항에 있어서, 헤테로아릴기는 피리딜, 티에닐, 푸릴, 이미다졸릴, 벤조푸라닐기 중에서 선택한 것임을 특징으로 하는 화합물.
  15. 삭제
  16. 제 1 항에 있어서, 다음 화학식 1 의 화합물 :

    화학식 1
    A-Z1-Z2-Z3-Z4-Z5-Z6-Z7-Z8-Z9-Z10-Z11-Z12-Z13-Z14-Z15-B
    (여기에서,
    A 는 -NH-R1 또는 R3-CO-NH- 기를 나타내고,
    여기에서,
    R1 은 수소, 비오틴 또는 피로글루탐산(Pyr), Pro(P), Val(V) 중에서 선택한 아미노산을 나타내고,
    R3 은 선형 또는 가지형 (C1-18) 알킬 사슬 중에서 선택한 것이고,

    B 는 -COOR2, -CONHR2 를 나타내고,
    여기에서, R2 는 제 1 항에 나타낸 바와 같고,

    각각의 Z1, Z3 및 Z12 는 동일하거나 상이할 수 있으며, 독립적으로 Ala(A), α-아미노-이소부티르산(Aib), 1-아미노 시클로프로판 카르복실산(AC3C), 1-아미노-시클로펜탄카르복실산(AC5C), 1-아미노-시클로헥산카르복실산(AC6C) 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내고 ;

    Z2 는 Val(V)를 나타내고 ;

    각각의 Z4, Z6 및 Z10 는 동일하거나 상이할 수 있으며, 독립적으로 Glu(E), Gln(Q), Aib 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내고 ;

    Z5, Z7 및 Z9 는 동일하거나 상이할 수 있으며, 독립적으로 Leu(L), Ile(I), Nle, HoLeu(호모류신), His(H), 알파-메틸-2-플루오로페닐알라닌(-α-Me-2F-Phe-), 알파-메틸-2,6-디플루로페닐알라닌(-α-Me-2,6-F-Phe-) 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내고 ;

    Z8은 Met, 알파-메틸-Met(αMe-M), Nle, N-메틸-Nle((NMe)Nle) 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내고 ;

    Z11 및 Z13 는 동일하거나 상이할 수 있으며, 독립적으로 Aib, αMe-Pro, 리신(K), 리신-비오틴(K(비오틴)), K(NO2), 아르기닌(R), Arg(NO2), 호모아르기닌(Har), 오르니틴(Orn), Orn(NO2), 시트룰린(Cit), 호모시트룰린(HoCit), 알파-메틸-2-플루오로페닐알라닌(-α-Me-2F-Phe-), 알파-메틸-2,6-디플루로페닐알라닌(-α-Me-2,6-F-Phe-) 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내고 ;

    Z14는 2'-에틸-4'-메톡시-비페닐알라닌(Bip(OMe)), α-메틸화 Bip(OMe)[αMe-Bip(OMe)], 알파-메틸-2-플루오로페닐알라닌(-α-Me-2F-Phe-), 알파-메틸-2,6-디플루로페닐알라닌(-α-Me-2,6-F-Phe-) 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타내며 ;

    Z15는 존재할 때 2-아미노-5-페닐발레르산(APPA) 또는 2-아미노-2-메틸-5-페닐발레르산(α-Me-APPA) 중에서 선택한 자연적으로 발생하는 아미노산 또는 자연적으로 발생하지 않는 아미노산을 나타낸다).
  17. 다음 중에서 선택한 화학식 Ⅰ의 화합물 ;
    Aib-V-Aib-EIQLMHQ-Har-AK-(α-Me-Phe);
    Aib-V-Aib-EIQL-Nle-HQ-Har-AK-(α-Me-Phe);
    Aib-V-Aib-EIQLMHQ-Har-(αMe-Pro)-K-(α-Me-Phe);
    Aib-V-Aib-EIQL-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-Phe);
    Aib-V-Aib-EIQLMHQ-Har-Aib-K-(α-Me-Phe);
    Aib-V-Aib-EIQL-Nle-HQ-Har-Aib-K-(α-Me-Phe);
    (AC3C)-V-Aib-EIQL-Nle-HQ-Har-AK-(α-Me-Phe);
    (AC3C)-V-Aib-EIQLMHQ-Har-(αMe-Pro)-K-(α-Me-Phe);
    (AC3C)-V-Aib-EIQL-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-Phe);
    (AC3C)-V-Aib-EIQLMHQ-Har-Aib-K-(α-Me-Phe);
    (AC3C)-V-Aib-EIQL-Nle-HQ-Har-Aib-K-(α-Me-Phe);
    Aib-V-(AC5C)-EIQLMHQ-Har-Aib-K-(α-Me-Phe);
    Aib-V-(AC5C)-EIQL-Nle-HQ-Har-Aib-K-(α-Me-Phe);
    (AC5C)-V-(AC5C)-EIQLMHQ-Har-(αMe-Pro)-K-(α-Me-Phe);
    (AC5C)-V-(AC5C)-EIQL-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-Phe);
    (AC5C)-V-Aib-EIQLMHQ-Har-Aib-K-(α-Me-Phe);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Har-Aib-K-(α-Me-Phe);
    Aib-V-(AC6C)-EIQLMHQ-Har-Aib-K-(α-Me-Phe);
    Aib-V-(AC6C)-EIQL-Nle-HQ-Har-Aib-K-(α-Me-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-AK-(α-Me-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-AK-(α-Me-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-AK-(α-Me-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-AK-(α-Me-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-AK-(α-Me-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-AK-(α-Me-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-AK-(α-Me-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-AK-(α-Me-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-H-(Abu(CN))-Har-AK-(α-Me-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-AK-(α-Me-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-M-HQ-Har-AK-(α-Me-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-M-HQ-Har-(αMe-Pro)-K-(α-Me-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-M-HQ-Har-Aib-K-(α-Me-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-AK-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-2F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-AK-(α-Me-2F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-2F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-2F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-AK-(α-Me-2F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-2F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-2F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-AK-(α-Me-2F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-2F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-AK-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-K(비오틴)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-AK-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-2F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-AK-(α-Me-2F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-2F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-2F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-AK-(α-Me-2F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-2F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-2F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-AK-(α-Me-2F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-2F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-AK-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-H-(Abu(CN))-Har-AK-(α-Me-2F-Phe);
    Aib-V-(AC6C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-AK-(α-Me-2F-Phe);
    Aib-V-(AC6C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-2F-Phe);
    Aib-V-(AC6C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-AK-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-2,6-F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-AK-(α-Me-2,6-F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-2,6-F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-2,6-F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-AK-(α-Me-2,6-F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-2,6-F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-2,6-F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-AK-(α-Me-2,6-F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-2,6-F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-AK-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-K(비오틴)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-AK-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-2,6-F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-AK-(α-Me-2,6-F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-2,6-F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-2,6-F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-AK-(α-Me-2,6-F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-2,6-F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-2,6-F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-AK-(α-Me-2,6-F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-2,6-F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-AK-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-(αMe-Pro)-K-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-K-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Cit-(α-Me-2F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Cit-(α-Me-2F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Cit-(α-Me-2F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Cit-(α-Me-2F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Cit-(α-Me-2F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Cit-(α-Me-2F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Cit-(α-Me-2F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Cit-(α-Me-2F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Cit-(α-Me-2F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Cit-(α-Me-2F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Cit-(α-Me-2F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Cit-(α-Me-2F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Cit-(α-Me-2,6-F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Cit-(α-Me-2,6-F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Cit-(α-Me-2,6-F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Cit-(α-Me-2,6-F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Cit-(α-Me-2,6-F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Cit-(α-Me-2,6-F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Cit-(α-Me-2,6-F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Cit-(α-Me-2,6-F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Aib-(α-Me-2F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Aib-(α-Me-2F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Aib-(α-Me-2F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Aib-(α-Me-2F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Aib-(α-Me-2F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Aib-(α-Me-2F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Aib-(α-Me-2F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Aib-(α-Me-2F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Aib-(α-Me-2F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Aib-(α-Me-2F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Aib-(α-Me-2F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Aib-(α-Me-2F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Aib-(α-Me-2,6-F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Aib-(α-Me-2,6-F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Aib-(α-Me-2,6-F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Aib-(α-Me-2,6-F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Aib-(α-Me-2,6-F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Aib-(α-Me-2,6-F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Aib-(α-Me-2,6-F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Aib-(α-Me-2,6-F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Arg(NO2)-(α-Me-2F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Arg(NO2)-(α-Me-2F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-(AC5C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-A-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-Aib-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-A-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-Aib-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-A-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-A-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-A-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-Aib-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-A-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-Aib-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-A-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-A-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-A-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-Aib-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-A-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-Aib-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-A-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-A-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-A-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-Aib-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-A-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-Aib-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-A-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-A-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-A-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-Aib-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-A-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-Aib-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-A-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-A-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Orn-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-A-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-Aib-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-A-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-Aib-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-A-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-A-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-A-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-Aib-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-A-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-Aib-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-A-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-A-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-A-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-Aib-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-A-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-Aib-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-A-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-A-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-A-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-Aib-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-A-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-Aib-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-A-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-A-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-A-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-Aib-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-A-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-Aib-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-A-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-A-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Cit-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-A-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-Aib-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-A-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-Aib-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-A-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-A-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-A-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-Aib-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-A-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-Aib-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-A-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-A-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-A-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-Aib-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-A-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-Aib-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-A-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-A-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-A-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-Aib-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-A-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-Aib-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-A-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-A-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-A-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-Aib-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-A-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-Aib-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-A-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-A-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(HoCit)-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-A-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-Aib-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-A-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-Aib-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-A-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-Aib-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-A-Cit-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-Aib-Cit-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-A-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-Aib-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-A-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-Aib-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-A-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-Aib-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-A-Cit-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-Aib-Cit-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-A-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-Aib-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-A-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-Aib-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-A-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-Aib-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-A-Aib-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-Aib-Aib-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-A-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-Aib-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-A-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-Aib-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-A-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-Aib-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-A-Aib-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-Aib-Aib-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-A-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-Aib-(α-Me-2,6-F-Phe)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-A-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe) ;
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-Aib-(α-Me-2,6-F-Phe)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-A-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-Aib-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-A-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-Aib-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-A-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-Aib-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-A-Arg(NO2)-(α-Me-2F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-Aib-Arg(NO2)-(α-Me-2F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-Aib-Arg(NO2)-(α-Me-2,6-F-Phe)
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Aib-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-A-Arg(NO2)-(α-Me-2,6-F-Phe);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Aib-Aib-Arg(NO2)-(α-Me-2,6-F-Phe);
    Aib-V-Aib-EIQLMHQ-Har-AK-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Har-AK-(Bip(OMe))-(APPA);
    (AC3C)-V-Aib-EIQLMHQ-Har-AK-(Bip(OMe))-(APPA);
    (AC3C)-V-Aib-EIQL-Nle-HQ-Har-AK-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQLMHQ-Har-AK-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Har-AK-(Bip(OMe))-(APPA);
    Aib-V-(AC3C)-EIQLMHQ-Har-AK-(Bip(OMe))-(APPA);
    Aib-V-(AC3C)-EIQL-Nle-HQ-Har-AK-(Bip(OMe))-(APPA);
    (AC3C)-V-(AC3C)-EIQLMHQ-Har-AK-(Bip(OMe))-(APPA);
    (AC3C)-V-(AC3C)-EIQL-Nle-HQ-Har-AK-(Bip(OMe))-(APPA);
    (AC5C)-V-(AC3C)-EIQLMHQ-Har-AK-(Bip(OMe))-(APPA);
    (AC5C)-V-(AC3C)-EIQL-Nle-HQ-Har-AK-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQLMHQ-Har(NO2)-AK-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Har(NO2)-AK-(Bip(OMe))-(APPA);
    (AC3C)-V-Aib-EIQLMHQ-Har(NO2)-AK-(Bip(OMe))-(APPA);
    (AC3C)-V-Aib-EIQL-Nle-HQ-Har(NO2)-AK-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQLMHQ-Har(NO2)-AK-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Har(NO2)-AK-(Bip(OMe))-(APPA);
    Aib-V-(AC3C)-EIQLMHQ-Har(NO2)-AK-(Bip(OMe))-(APPA);
    Aib-V-(AC3C)-EIQL-Nle-HQ-Har(NO2)-AK-(Bip(OMe))-(APPA);
    (AC3C)-V-(AC3C)-EIQLMHQ-Har(NO2)-AK-(Bip(OMe))-(APPA);
    (AC3C)-V-(AC3C)-EIQL-Nle-HQ-Har(NO2)-AK-(Bip(OMe))-(APPA);
    (AC5C)-V-(AC3C)-EIQLMHQ-Har(NO2)-AK-(Bip(OMe))-(APPA);
    (AC5C)-V-(AC3C)-EIQL-Nle-HQ-Har(NO2)-AK-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQLMHQ-Har(NO2)-A-K(비오틴)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Har(NO2)-A-K(비오틴)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQLMHQ-Har-A-K(비오틴)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Har-A-K(비오틴)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQLMHQ-Har(NO2)-A-K(-CO-(CH2)6-CH3)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Har(NO2)-A-K(-CO-(CH2)6-CH3)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQLMHQ-Har-A-K(-CO-(CH2)6-CH3)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Har-A-K(-CO-(CH2)6-CH3)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQLMHQ-Har(NO2)-A-K(-CO-(CH2)8-CH3)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Har(NO2)-A-K(-CO-(CH2)8-CH3)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQLMHQ-Har-A-K(-CO-(CH2)8-CH3)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Har-A-K(-CO-(CH2)8-CH3)-(Bip(OMe))-(APPA);
    (AC5C)-V-(AC3C)-EIQL-Nle-HQ-Har-A-K(-CO-(CH2)8-CH3)-(Bip(OMe))-(APPA);
    (AC5C)-V-(AC3C)-EIQLMHQ-Har(NO2)-A-(NMe)K-(Bip(OMe))-(APPA);
    (AC5C)-V-(AC3C)-EIQL-Nle-HQ-Har(NO2)-A-(NMe)K-(Bip(OMe))-(APPA);
    (AC5C)-V-(AC3C)-EIQL-(NMe)M-HQ-Har-A-K(-CO-(CH2)8-CH3)-(Bip(OMe))-(APPA);
    (AC5C)-V-(AC3C)-EIQL-(NMe)Nle-HQ-Har-A-K(-CO-(CH2)8-CH3)-(Bip(OMe))-(APPA);
    (AC3C)-V-(AC3C)-EIQL-(NMe)M-HQ-Har(NO2)-A-(NMe)K-(Bip(OMe))-(APPA);
    (AC3C)-V-(AC3C)-EIQL-(NMe)Nle-HQ-Har(NO2)-A-(NMe)K-(Bip(OMe))-(APPA);
    (AC5C)-V-(AC3C)-EIQL-(NMe)M-HQ-Har(NO2)-A-(NMe)K-(Bip(OMe))-(APPA);
    (AC5C)-V-(AC3C)-EIQL-(NMe)Nle-HQ-Har(NO2)-A-(NMe)K-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQLMHQ-Har-AK-(Bip(OMe));
    Aib-V-Aib-EIQL-Nle-HQ-Har-AK-(Bip(OMe));
    (AC3C)-V-Aib-EIQLMHQ-Har-AK-(Bip(OMe));
    (AC3C)-V-Aib-EIQL-Nle-HQ-Har-AK-(Bip(OMe));
    (AC5C)-V-Aib-EIQLMHQ-Har-AK-(Bip(OMe));
    (AC5C)-V-Aib-EIQL-Nle-HQ-Har-AK-(Bip(OMe));
    Aib-V-(AC3C)-EIQLMHQ-Har-AK-(Bip(OMe));
    Aib-V-(AC3C)-EIQL-Nle-HQ-Har-AK-(Bip(OMe));
    (AC3C)-V-(AC3C)-EIQLMHQ-Har-AK-(Bip(OMe));
    (AC3C)-V-(AC3C)-EIQL-Nle-HQ-Har-AK-(Bip(OMe));
    (AC5C)-V-(AC3C)-EIQLMHQ-Har-AK-(Bip(OMe));
    (AC5C)-V-(AC3C)-EIQL-Nle-HQ-Har-AK-(Bip(OMe));
    Aib-V-Aib-EIQLMHQ-Har(NO2)-AK-(Bip(OMe));
    Aib-V-Aib-EIQL-Nle-HQ-Har(NO2)-AK-(Bip(OMe));
    Aib-V-Aib-EIQLMHQ-Har(NO2)-A-K(비오틴)-(Bip(OMe));
    Aib-V-Aib-EIQL-Nle-HQ-Har(NO2)-A-K(비오틴)-(Bip(OMe));
    Aib-V-Aib-EIQLMHQ-Har-A-K(비오틴)-(Bip(OMe));
    Aib-V-Aib-EIQL-Nle-HQ-Har-A-K(비오틴)-(Bip(OMe));
    Aib-V-Aib-EIQLMHQ-Har(NO2)-A-K(-CO-(CH2)6-CH3)-(Bip(OMe));
    Aib-V-Aib-EIQL-Nle-HQ-Har(NO2)-A-K(-CO-(CH2)6-CH3)-(Bip(OMe));
    Aib-V-Aib-EIQLMHQ-Har-A-K(-CO-(CH2)6-CH3)-(Bip(OMe));
    Aib-V-Aib-EIQL-Nle-HQ-Har-A-K(-CO-(CH2)6-CH3)-(Bip(OMe));
    Aib-V-Aib-EIQLMHQ-Har(NO2)-A-K(-CO-(CH2)8-CH3)-(Bip(OMe));
    Aib-V-Aib-EIQL-Nle-HQ-Har(NO2)-A-K(-CO-(CH2)8-CH3)-(Bip(OMe));
    Aib-V-Aib-EIQLMHQ-Har-A-K(-CO-(CH2)8-CH3)-(Bip(OMe));
    Aib-V-Aib-EIQL-Nle-HQ-Har-A-K(-CO-(CH2)8-CH3)-(Bip(OMe));
    (AC5C)-V-(AC3C)-EIQLMHQ-Har-A-K(-CO-(CH2)8-CH3)-(Bip(OMe));
    (AC5C)-V-(AC3C)-EIQL-Nle-HQ-Har-A-K(-CO-(CH2)8-CH3)-(Bip(OMe));
    (AC5C)-V-(AC3C)-EIQLMHQ-Har(NO2)-A-(NMe)K-(Bip(OMe));
    (AC5C)-V-(AC3C)-EIQL-Nle-HQ-Har(NO2)-A-(NMe)K-(Bip(OMe));

    Aib-V-Aib-EIQL-(NMe)M-HQ-Har-A-K(-CO-(CH2)8-CH3)-(Bip(OMe));
    Aib-V-Aib-EIQL-(NMe)Nle-HQ-Har-A-K(-CO-(CH2)8-CH3)-(Bip(OMe));
    (AC3C)-V-Aib-EIQL-(NMe)M-HQ-Har-A-K(-CO-(CH2)8-CH3)-(Bip(OMe));
    (AC3C)-V-Aib-EIQL-(NMe)Nle-HQ-Har-A-K(-CO-(CH2)8-CH3)-(Bip(OMe));
    Aib-V-Aib-EIQLMHQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    (AC3C)-V-Aib-EIQLMHQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    (AC3C)-V-Aib-EIQL-Nle-HQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQLMHQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQLMHQ-Har-Aib-Arg(NO2)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    Aib-V-(AC3C)-EIQLMHQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    Aib-V-(AC3C)-EIQL-Nle-HQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    (AC3C)-V-(AC3C)-EIQLMHQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    (AC3C)-V-(AC3C)-EIQL-Nle-HQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    (AC5C)-V-(AC3C)-EIQLMHQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    (AC5C)-V-(AC3C)-EIQL-Nle-HQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    Aib-V-(AC3C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    (AC3C)-V-(AC3C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    (AC5C)-V-(AC3C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    Aib-V-(AC3C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    (AC3C)-V-(AC3C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    (AC5C)-V-(AC3C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2,6-F-Phe)-(APPA);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2,6-F-Phe)-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2,6-F-Phe)-(APPA);
    Aib-V-(AC3C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2,6-F-Phe)-(APPA);
    (AC3C)-V-(AC3C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2,6-F-Phe)-(APPA);
    (AC5C)-V-(AC3C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2,6-F-Phe)-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2,6-F-Phe)-(APPA);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2,6-F-Phe)-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2,6-F-Phe)-(APPA);
    Aib-V-(AC3C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2,6-F-Phe)-(APPA);
    (AC3C)-V-(AC3C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2,6-F-Phe)-(APPA);
    (AC5C)-V-(AC3C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2,6-F-Phe)-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2F-Phe)-(APPA);
    (AC3C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2F-Phe)-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2F-Phe)-(APPA);
    Aib-V-(AC3C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2F-Phe)-(APPA);
    (AC3C)-V-(AC3C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2F-Phe)-(APPA);
    (AC5C)-V-(AC3C)-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2F-Phe)-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2F-Phe)-(APPA);
    (AC3C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2F-Phe)-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2F-Phe)-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-Aib-Arg(NO2)-(α-Me-2F-Phe)-(APPA);
    Aib-V-(AC3C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2F-Phe)-(APPA);
    (AC3C)-V-(AC3C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2F-Phe)-(APPA);
    (AC5C)-V-(AC3C)-EIQ-(α-Me-2F-Phe)-Nle-HQ-Har-A-Arg(NO2)-(α-Me-2F-Phe)-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Har-AR-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Har-AR-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Har-A-Cit-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Har-A-Cit-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Har-A-Aib-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Har-A-Aib-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Har-Aib-R-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Har-Aib-R-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Har-Aib-Cit-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Har-Aib-Cit-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Har-Aib-Aib-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Har-Aib-Aib-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Orn-AR-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Orn-AR-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Orn-A-Cit-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Orn-A-Cit-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Orn-A-Aib-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Orn-A-Aib-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Orn-A-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Orn-A-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Orn-Aib-R-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Orn-Aib-R-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Orn-Aib-Cit-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Orn-Aib-Cit-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Orn-Aib-Aib-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Orn-Aib-Aib-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Orn-Aib-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Orn-Aib-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Cit-AR-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Cit-AR-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Cit-A-Cit-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Cit-A-Cit-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Cit-A-Aib-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Cit-A-Aib-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Cit-A-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Cit-A-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Cit-Aib-R-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Cit-Aib-R-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Cit-Aib-Cit-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Cit-Aib-Cit-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Cit-Aib-Aib-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Cit-Aib-Aib-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Cit-Aib-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-Cit-Aib-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-(HoCit)-AR-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-(HoCit)-AR-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-(HoCit)-A-Cit-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-(HoCit)-A-Cit-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-(HoCit)-A-Aib-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-(HoCit)-A-Aib-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-(HoCit)-A-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-(HoCit)-A-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-(HoCit)-Aib-R-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-(HoCit)-Aib-R-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-(HoCit)-Aib-Cit-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-(HoCit)-Aib-Cit-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-(HoCit)-Aib-Aib-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-(HoCit)-Aib-Aib-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-(HoCit)-Aib-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-(HoCit)-Aib-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-(α-Me-2,6-F-Phe)-AR-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-(α-Me-2,6-F-Phe)-AR-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-(α-Me-2,6-F-Phe)-A-Cit-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-(α-Me-2,6-F-Phe)-A-Cit-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-(α-Me-2,6-F-Phe)-A-Aib-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-(α-Me-2,6-F-Phe)-A-Aib-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-(α-Me-2,6-F-Phe)-A-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-(α-Me-2,6-F-Phe)-A-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-R-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-R-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Cit-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Cit-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Aib-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Aib-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQL-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-AR-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-AR-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Cit-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Cit-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Aib-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-Aib-(Bip(OMe))-(APPA)'
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-A-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-R-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-R-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Cit-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Cit-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Aib-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-Aib-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Har-Aib-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-AR-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-AR-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-A-Cit-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-A-Cit-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-A-Aib-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-A-Aib-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-A-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-A-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-R-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-R-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-Cit-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-Cit-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-Aib-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-Aib-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Orn-Aib-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-AR-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-AR-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-A-Cit-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-A-Cit-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-A-Aib-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-A-Aib-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-A-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-A-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-R-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-R-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-Cit-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-Cit-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-Aib-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-Aib-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-Cit-Aib-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-AR-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-AR-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-A-Cit-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-A-Cit-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-A-Aib-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-A-Aib-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-A-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-A-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-R-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-R-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-Cit-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-Cit-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-Aib-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-Aib-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(HoCit)-Aib-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-AR-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-AR-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Cit-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Cit-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Aib-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-Aib-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-A-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-R-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-R-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Cit-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Cit-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Aib-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-Aib-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    (AC5C)-V-Aib-EIQ-(α-Me-2,6-F-Phe)-Nle-HQ-(α-Me-2,6-F-Phe)-Aib-(α-Me-2,6-F-Phe)-(Bip(OMe))-(APPA);
    Aib-V-Aib-EIQLMHQ-Har-AK-(αMe-Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Har-AK-(αMe-Bip(OMe))-(APPA);
    V-Aib-V-Aib-EIQLMHQ-Har-AK-(Bip(OMe))-(αMe-APPA);
    V-Aib-V-Aib-EIQL-Nle-HQ-Har-AK-(Bip(OMe))-(αMe-APPA);
    (αMe-V)-(AC5C)-V-Aib-EIQLMHQ-Har-AK-(Bip(OMe))-(αMe-APPA);
    (αMe-V)-(AC5C)-V-Aib-EIQL-Nle-HQ-Har-AK-(Bip(OMe))-(αMe-APPA);
    (NMe-V)-(AC5C)-V-Aib-EIQLMHQ-Har-AK-(Bip(OMe))-(αMe-APPA);
    (NMe-V)-(AC5C)-V-Aib-EIQL-Nle-HQ-Har-AK-(Bip(OMe))-(αMe-APPA);
    Aib-V-Aib-EIQLMHQ-Har-A-Har-(αMe-Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Har-A-Har-(αMe-Bip(OMe))-(APPA);
    Aib-V-Aib-EIQLMHQ-Har-A-Har-(Bip(OMe))-(αMe-APPA);
    Aib-V-Aib-EIQL-Nle-HQ-Har-A-Har-(Bip(OMe))-(αMe-APPA);
    V-Aib-V-Aib-EIQLMHQ-Har-A-Har-(αMe-Bip(OMe))-(APPA);
    V-Aib-V-Aib-EIQL-Nle-HQ-Har-A-Har-(αMe-Bip(OMe))-(APPA);
    V-Aib-V-Aib-EIQLMHQ-Har-A-Har-(Bip(OMe))-(αMe-APPA);
    V-Aib-V-Aib-EIQL-Nle-HQ-Har-A-Har-(Bip(OMe))-(αMe-APPA);
    (αMe-V)-(AC5C)-V-Aib-EIQLMHQ-Har-A-Har-(Bip(OMe))-(αMe-APPA);
    (αMe-V)-(AC5C)-V-Aib-EIQL-Nle-HQ-Har-A-Har-(Bip(OMe))-(αMe-APPA);
    (NMe-V)-(AC5C)-V-Aib-EIQLMHQ-Har-A-Har-(Bip(OMe))-(αMe-APPA);
    (NMe-V)-(AC5C)-V-Aib-EIQL-Nle-HQ-Har-A-Har-(Bip(OMe))-(αMe-APPA);
    Aib-V-Aib-EIQL-(αMe-M)-HQ-Har-A-Har-(αMe-Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-(αMe-Nle)-HQ-Har-A-Har-(αMe-Bip(OMe))-(APPA);
    Aib-V-Aib-EIQL-(αMe-M)-HQ-Har-A-Har-(Bip(OMe))-(αMe-APPA);
    Aib-V-Aib-EIQL-(αMe-Nle)-HQ-Har-A-Har-(Bip(OMe))-(αMe-APPA);
    V-Aib-V-Aib-EIQL-(αMe-M)-HQ-Har-A-Har-(αMe-Bip(OMe))-(APPA);
    V-Aib-V-Aib-EIQL-(αMe-Nle)-HQ-Har-A-Har-(αMe-Bip(OMe))-(APPA);
    V-(AC3C)-V-Aib-EIQL-(αMe-M)-HQ-Har-A-Har-(αMe-Bip(OMe))-(APPA);
    V-(AC3C)-V-Aib-EIQL-(αMe-Nle)-HQ-Har-A-Har-(αMe-Bip(OMe))-(APPA);
    V-(AC5C)-V-Aib-EIQL-(αMe-M)-HQ-Har-A-Har-(αMe-Bip(OMe))-(APPA);
    V-(AC5C)-V-Aib-EIQL-(αMe-Nle)-HQ-Har-A-Har-(αMe-Bip(OMe))-(APPA);
    V-Aib-V-Aib-EIQL-(αMe-M)-HQ-Har-A-Har-(Bip(OMe))-(αMe-APPA);
    V-Aib-V-Aib-EIQL-(αMe-Nle)-HQ-Har-A-Har-(Bip(OMe))-(αMe-APPA);
    V-(AC3C)-V-Aib-EIQL-(αMe-M)-HQ-Har-A-Har-(Bip(OMe))-(αMe-APPA);
    V-(AC3C)-V-Aib-EIQL-(αMe-Nle)-HQ-Har-A-Har-(Bip(OMe))-(αMe-APPA);
    V-(AC5C)-V-Aib-EIQL-(αMe-M)-HQ-Har-A-Har-(Bip(OMe))-(αMe-APPA);
    V-(AC5C)-V-Aib-EIQL-(αMe-Nle)-HQ-Har-A-Har-(Bip(OMe))-(αMe-APPA);
    (αMe-V)-(AC5C)-V-Aib-EIQL-(αMe-M)-HQ-Har-A-Har-(Bip(OMe))-(αMe-APPA);
    (αMe-V)-(AC5C)-V-Aib-EIQL-(αMe-Nle)-HQ-Har-A-Har-(Bip(OMe))-(αMe-APPA);
    (NMe-V)-(AC5C)-V-Aib-EIQL-(αMe-M)-HQ-Har-A-Har-(Bip(OMe))-(αMe-APPA);
    (NMe-V)-(AC5C)-V-Aib-EIQL-(αMe-Nle)-HQ-Har-A-Har-(Bip(OMe))-(αMe-APPA);
    Aib-V-Aib-EIQL-(αMe-M)-HQ-Har-A-Har-(αMe-2FPhe)-(APPA);
    Aib-V-Aib-EIQL-(αMe-Nle)-HQ-Har-A-Har-(αMe-2FPhe)-(APPA);
    V-Aib-V-Aib-EIQL-(αMe-M)-HQ-Har-A-Har-(αMe-2FPhe)-(αMe-APPA);
    V-Aib-V-Aib-EIQL-(αMe-Nle)-HQ-Har-A-Har-(αMe-2FPhe)-(αMe-APPA);
    V-(AC3C)-V-Aib-EIQL-(αMe-M)-HQ-Har-A-Har-(αMe-2FPhe)-(αMe-APPA);
    V-(AC3C)-V-Aib-EIQL-(αMe-Nle)-HQ-Har-A-Har-(αMe-2FPhe)-(αMe-APPA);
    V-(AC5C)-V-Aib-EIQL-(αMe-M)-HQ-Har-A-Har-(αMe-2FPhe)-(αMe-APPA);
    V-(AC5C)-V-Aib-EIQL-(αMe-Nle)-HQ-Har-A-Har-(αMe-2FPhe)-(αMe-APPA);
    (αMe-V)-(AC5C)-V-Aib-EIQL-(αMe-M)-HQ-Har-A-Har-(αMe-2FPhe)-(αMe-APPA);
    (αMe-V)-(AC5C)-V-Aib-EIQL-(αMe-Nle)-HQ-Har-A-Har-(αMe-2FPhe)-(αMe-APPA);
    (NMe-V)-(AC5C)-V-Aib-EIQL-(αMe-M)-HQ-Har-A-Har-(αMe-2FPhe)-(αMe-APPA);
    (NMe-V)-(AC5C)-V-Aib-EIQL-(αMe-Nle)-HQ-Har-A-Har-(αMe-2FPhe)-(αMe-APPA);
    Aib-V-Aib-EIQL-(αMe-M)-HQ-Har-A-Har-(αMe-Trp)-(APPA);
    Aib-V-Aib-EIQL-(αMe-Nle)-HQ-Har-A-Har-(αMe-Trp)-(APPA);
    (AC3C)-V-Aib-EIQL-(αMe-M)-HQ-Har-A-Har-(αMe-Trp)-(APPA);
    (AC3C)-V-Aib-EIQL-(αMe-Nle)-HQ-Har-A-Har-(αMe-Trp)-(APPA);
    (AC5C)-V-Aib-EIQL-(αMe-M)-HQ-Har-A-Har-(αMe-Trp)-(APPA);
    (AC5C)-V-Aib-EIQL-(αMe-Nle)-HQ-Har-A-Har-(αMe-Trp)-(APPA);
    Aib-V-Aib-EIQL-(αMe-M)-HQ-Har-A-Har-(αMe-Trp)-(αMe-APPA);
    Aib-V-Aib-EIQL-(αMe-Nle)-HQ-Har-A-Har-(αMe-Trp)-(αMe-APPA);
    V-(AC3C)-V-Aib-EIQL-(αMe-M)-HQ-Har-A-Har-(αMe-Trp)-(αMe-APPA);
    V-(AC3C)-V-Aib-EIQL-(αMe-Nle)-HQ-Har-A-Har-(αMe-Trp)-(αMe-APPA);
    V-(AC5C)-V-Aib-EIQL-(αMe-M)-HQ-Har-A-Har-(αMe-Trp)-(αMe-APPA);
    V-(AC5C)-V-Aib-EIQL-(αMe-Nle)-HQ-Har-A-Har-(αMe-Trp)-(αMe-APPA);
    (αMe-V)-(AC5C)-V-Aib-EIQL-(αMe-M)-HQ-Har-A-Har-(αMe-Trp)-(αMe-APPA);
    (αMe-V)-(AC5C)-V-Aib-EIQL-(αMe-Nle)-HQ-Har-A-Har-(αMe-Trp)-(αMe-APPA).
  18. PTH-1 수용체의 작용물질로서 작용하는, 골다공증의 진행 또는 발현을 지연시키거나 치료하기 위한, 제1항 내지 제14항, 제16항 및 제17항 중 어느 한 항에 따른 화학식 1 의 화합물 및 약제학적으로 허용되는 부형제를 포함하는 약제학적 조성물.
  19. PTH-1 수용체의 작용물질로서 작용하는, 초기 골다공증, 내분비성 골다공증(endocrine osteoporosis), 폐경후 골다공증, 유전적이고 선천적인 형태의 골다공증의 진행 또는 발현을 지연시키거나 치료하기 위한, 제1항 내지 제14항, 제16항 및 제17항 중 어느 한 항에 따른 화학식 1 의 화합물.
  20. 제1항 내지 제14항, 제16항 및 제17항 중 어느 한 항에 따른 화학식 1 의 화합물을 인간을 제외한 이를 필요로 하는 피검자에게 독성을 나타내지 않는 유효량으로 투여하는 것을 포함하는, 초기 골다공증, 내분비성 골다공증, 유전적이고 선천적인 형태의 골다공증, 부동화(immobilization), 만성 폐쇄성 폐질환(chronic obstructive pulmonary disease) 또는 류마티스성 질환에 의한 골다공증, 골수염 또는 뼈 손실의 합병증을 유발하는 뼈에서의 전염성 병변(infectious lesion in bone)에 의해 발생된 질병의 예방 및 치료방법.
  21. 제1항 내지 제14항, 제16항 및 제17항 중 어느 한 항에 따른 화학식 1 의 화합물 및 약제학적으로 허용되는 담체, 희석제, 부형제를 인간을 제외한 이를 필요로 하는 피검자에게 투여하는 것을 포함하는, 초기 골다공증, 내분비성 골다공증, 유전적이고 선천적인 형태의 골다공증, 부동화, 만성 폐쇄성 폐질환 또는 류마티스성 질환에 의한 골다공증, 골수염 또는 뼈 손실의 합병증을 유발하는 뼈에서의 전염성 병변에 의해 발생된 질병을 치료하거나 감소시키기 위한 의약.
  22. 삭제
  23. PTH-1 수용체의 작용물질로서 작용하는, 초기 골다공증, 내분비성 골다공증, 폐경후 골다공증, 유전적이고 선천적인 형태의 골다공증의 진행 또는 발현을 지연시키거나 치료하기 위한, 제1항 내지 제14항, 제16항 및 제17항 중 어느 한 항에 따른 화학식 1 의 화합물 및 약제학적으로 허용되는 부형제를 포함하는 약제학적 조성물.
KR1020117026057A 2009-04-24 2010-04-26 부갑상선호르몬(ｐｔｈ) 수용체 작용물질로서의 단쇄 펩티드 KR101451470B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN1095/MUM/2009 2009-04-24
IN1095MU2009 2009-04-24
IN225MU2010 2010-01-28
IN225/MUM/2010 2010-01-28
PCT/IN2010/000264 WO2010128521A2 (en) 2009-04-24 2010-04-26 Short-chain peptides as parathyroid hormone (pth) receptor agonist

Publications (2)

Publication Number Publication Date
KR20120034606A KR20120034606A (ko) 2012-04-12
KR101451470B1 true KR101451470B1 (ko) 2014-10-15

Family

ID=43050579

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020117026057A KR101451470B1 (ko) 2009-04-24 2010-04-26 부갑상선호르몬(ｐｔｈ) 수용체 작용물질로서의 단쇄 펩티드

Country Status (15)

Country Link
US (1) US8383581B2 (ko)
EP (1) EP2421893A2 (ko)
JP (1) JP5744844B2 (ko)
KR (1) KR101451470B1 (ko)
CN (1) CN102405229A (ko)
AU (1) AU2010245642A1 (ko)
BR (1) BRPI1008103A2 (ko)
CA (1) CA2757874C (ko)
EA (1) EA022212B1 (ko)
IL (1) IL215625A (ko)
MX (1) MX2011010968A (ko)
NZ (1) NZ595437A (ko)
SG (1) SG174532A1 (ko)
WO (1) WO2010128521A2 (ko)
ZA (1) ZA201107078B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928487A (en) * 1974-11-27 1975-12-23 Standard Oil Co Alkylation process utilizing hydrofluoric acid with a minor amount of fluorosulfuric acid
UY32099A (es) 2008-09-11 2010-04-30 Enanta Pharm Inc Inhibidores macrocíclicos de serina proteasas de hepatitis c
WO2012092409A2 (en) 2010-12-30 2012-07-05 Enanta Phararmaceuticals, Inc Macrocyclic hepatitis c serine protease inhibitors
EA201390988A1 (ru) 2010-12-30 2014-04-30 Энанта Фармасьютикалз, Инк. Фенантридиновые макроциклические ингибиторы сериновой протеазы вируса гепатита c
WO2012120532A2 (en) 2011-02-02 2012-09-13 Cadila Healthcare Limited Cyclic short chain peptides
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
WO2015103490A1 (en) 2014-01-03 2015-07-09 Abbvie, Inc. Solid antiviral dosage forms
WO2024187241A1 (en) * 2023-03-16 2024-09-19 The Florey Institute Of Neuroscience And Mental Health Stapled peptides

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003009804A2 (en) * 2001-07-23 2003-02-06 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
WO2004067021A1 (en) 2003-01-24 2004-08-12 Gardella Thomas J Conformationally constrained parathyroid hormone (pth) analogs with lactam bridges
US20070111946A1 (en) 1998-10-22 2007-05-17 Gardella Thomas J Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001023521A2 (en) * 1999-09-29 2001-04-05 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (pth)
EP1222208B1 (en) * 1999-09-29 2008-10-29 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (pth)
AU2002951372A0 (en) 2002-09-13 2002-09-26 St Vincent's Institute Of Medical Research Parathyroid hormone-like polypeptides
EP1610813A4 (en) 2003-03-19 2009-07-01 Gen Hospital Corp PARATHYROIDAL HORMONES CONFORMALLY CONFORMALLY CONSTRAINED WITH PROPELLER STABILIZERS $ G (A)
EP1653985A4 (en) 2003-07-17 2009-08-05 Gen Hospital Corp CONSTRAINTS CONTAINING CONTAINING HORMONE PARATHYROID (PTH) ANALOGUES
JP2007522215A (ja) 2004-02-11 2007-08-09 スミスクライン・ビーチャム・コーポレイション Ｐｔｈアゴニスト
EP1713815A4 (en) 2004-02-11 2009-03-11 Smithkline Beecham Corp PTH AGONISTS
ITMI20041440A1 (it) 2004-07-19 2004-10-19 Abiogen Pharma Spa Peptidi analoghi del pth-1-11
US20070099831A1 (en) 2005-09-06 2007-05-03 Paul Morley Parathyroid hormone analogues and methods of use
EP1961765A1 (en) 2006-12-08 2008-08-27 Zealand Pharma A/S Truncated PTH peptides with a cyclic conformation
AU2008282805B2 (en) * 2007-08-01 2014-05-01 Chugai Pharmaceutical Co., Ltd. Screening methods using G-protein coupled receptors and related compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070111946A1 (en) 1998-10-22 2007-05-17 Gardella Thomas J Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP)
WO2003009804A2 (en) * 2001-07-23 2003-02-06 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
WO2004067021A1 (en) 2003-01-24 2004-08-12 Gardella Thomas J Conformationally constrained parathyroid hormone (pth) analogs with lactam bridges

Also Published As

Publication number Publication date
AU2010245642A1 (en) 2011-10-27
CN102405229A (zh) 2012-04-04
ZA201107078B (en) 2014-03-26
EP2421893A2 (en) 2012-02-29
EA022212B1 (ru) 2015-11-30
BRPI1008103A2 (pt) 2016-05-03
WO2010128521A3 (en) 2011-03-10
CA2757874A1 (en) 2010-11-11
MX2011010968A (es) 2012-01-19
JP5744844B2 (ja) 2015-07-08
WO2010128521A2 (en) 2010-11-11
EA201171292A1 (ru) 2012-05-30
US20120108496A1 (en) 2012-05-03
KR20120034606A (ko) 2012-04-12
JP2012524775A (ja) 2012-10-18
IL215625A0 (en) 2012-01-31
NZ595437A (en) 2014-03-28
CA2757874C (en) 2016-02-16
US8383581B2 (en) 2013-02-26
IL215625A (en) 2016-12-29
SG174532A1 (en) 2011-10-28

Similar Documents

Publication Publication Date Title
KR101451470B1 (ko) 부갑상선호르몬(ｐｔｈ) 수용체 작용물질로서의 단쇄 펩티드
Bourgault et al. Novel stable PACAP analogs with potent activity towards the PAC1 receptor
KR0173478B1 (ko) 부갑상선 호르몬 길항물질
EP1958957A1 (en) Polypeptide comprising a knottin protein moiety
EP2320927B1 (en) Modified peptides as potent inhibitors of the psd-95/nmda receptor interaction
CZ20003798A3 (cs) Způsob výroby cyklických peptidů vázaných k polymernímu nosiči
US5093233A (en) Antagonists with position 13 modification
JPS63313800A (ja) 副甲状腺ホルモン拮抗剤
Kowalczyk et al. Synthesis and evaluation of disulfide bond mimetics of amylin-(1–8) as agents to treat osteoporosis
HRP970416A2 (en) Method for the synthesis of analogs of parathyroid hormone and parathyroid hormone related peptide
De Prins et al. Development of potent and proteolytically stable human neuromedin U receptor agonists
JPH10510814A (ja) ベタイドを製造するためのアミノ酸並びにベタイドライブラリーのスクリーニング方法及び製造方法
KR20010085847A (ko) 펩티드 유도체
HUT69708A (en) Process for producing parathormon fragments and pharmaceutical compositions containing them
WO1996003437A1 (en) PTH OR PTHrP ANTAGONISTS
EP3650464A1 (en) Peptide compound and application thereof, and composition containing peptide compound
WO2012120532A2 (en) Cyclic short chain peptides
WO2019087161A1 (en) Peptide conjugate cgrp receptor antagonists and methods of preparation and uses thereof
Magafa et al. Synthesis and biological activity of oxytocin analogues containing unnatural amino acids in position 9: structure activity study
Rajeswaran et al. Exploration of the DTrp-NMeLys motif in the search for potent somatostatin antagonists
US20090042802A1 (en) Compounds and peptides that bind the kgf receptor
AU736207B2 (en) Peptides which promote activation of latent TGF-beta and method of screening TGF-beta activity-regulating compounds
Fragiadaki et al. Synthesis and biological activity of oxytocin analogues containing conformationally-restricted residues in position 7
Chorev et al. Biological activity of parathyroid hormone antagonists substituted at position 13
Fragiadaki et al. Synthesis and biological evaluation of oxytocin analogues containing l-α-t-butylglycine [Gly (But)] in positions 8 or 9

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee